Surgical treatment of stress urinary incontinence in women. The shift from Burch colposuspension to the retropubic tension-free vaginal tape procedure by Holdø, Bjørn
1 
UiT The Arctic University of Norway 
Faculty of Health Sciences       
Department of community medicine 
Surgical treatment of stress 
urinary incontinence in women 
The shift from Burch colposuspension to the retropubic tension-
free vaginal tape procedure 
Bjørn Holdø 
A dissertation for the degree of Philosophiae Doctor 




1 Acknowledgements .................................................................................................................... 5 
2 Abbreviations .............................................................................................................................. 6 
3 List of papers .............................................................................................................................. 7 
3.1 Paper I ...................................................................................................................................... 7 
3.2 Paper II ..................................................................................................................................... 7 
3.3 Paper III .................................................................................................................................... 7 
4 Abstract ...................................................................................................................................... 8 
5 Summary in Norwegian (Sammendrag på norsk) ..................................................................... 10 
6 Introduction .............................................................................................................................. 12 
6.1 Definitions - Urinary incontinence in women ....................................................................... 12 
6.2 Epidemiology and risk factors ............................................................................................... 13 
6.3 Urinary incontinence, pelvic floor anatomy, and pathophysiology ...................................... 13 
6.3.1 Pelvic floor anatomy and the urethral support system............................................. 13 
6.3.2 The three mechanisms of continence ....................................................................... 16 
6.3.3 Mechanisms of stress urinary incontinence .............................................................. 17 
6.3.4 Mixed urinary incontinence ...................................................................................... 19 
6.3.5 Overactive bladder .................................................................................................... 20 
6.4 Non-surgical treatment of stress urinary incontinence – pelvic floor muscle training ......... 20 
6.5 Surgical treatment of stress urinary incontinence ................................................................ 21 
6.5.1 Retropubic bladder neck suspension - the Marshall-Marchetti-Krantz procedure and 
the Burch colposuspension ....................................................................................... 21 
6.5.2 The modern midurethral sling ................................................................................... 23 
7 Background for the study and aims of the thesis ..................................................................... 25 
7.1 Transition from the Burch colposuspension to the retropubic tension-free vaginal tape 
             procedure .............................................................................................................................. 25
7.2 Effectiveness of the retropubic tension-free vaginal tape procedure .................................. 25 
7.3 Safety of the tension-free vaginal tape procedure ............................................................... 26 
7.4 The importance of surgeon’s experience in the clinical outcomes of the tension-free vaginal 
tape procedure ...................................................................................................................... 26 
7.5 Aims of the thesis .................................................................................................................. 27 
8 Materials and methods ............................................................................................................ 28 
8.1 Study design .......................................................................................................................... 28 
8.2 Study population ................................................................................................................... 28 
8.3 Data collection ....................................................................................................................... 31 
8.3.1 Demographic and pre-, peri-, and postoperative variables ...................................... 32 
8.4 Definitions ............................................................................................................................. 34 
8.4.1 Type of urinary incontinence..................................................................................... 34 
4 
8.4.2 Recurrence of urinary incontinence .......................................................................... 34 
8.4.3 Complications ............................................................................................................ 34 
8.4.4 Follow-up ................................................................................................................... 36 
8.4.5 Main exposure and outcomes ................................................................................... 36 
8.5 Statistical analysis .................................................................................................................. 37 
8.6 Ethical approval ..................................................................................................................... 39 
9 Main results .............................................................................................................................. 39 
9.1 Primary outcome - recurrence .............................................................................................. 39 
9.2 Secondary outcomes ............................................................................................................. 40 
9.2.1 Perioperative complications ...................................................................................... 40 
9.2.2 Voiding dysfunction/urinary retention...................................................................... 41 
9.2.3 Late complications ..................................................................................................... 41 
10 Discussion ................................................................................................................................. 42 
10.1 Primary outcome - recurrence .............................................................................................. 42 
10.2 Secondary outcomes ............................................................................................................. 45 
10.2.1 Comparison of the Burch colposuspension and the tension-free vaginal tape 
procedure ................................................................................................................. 45
10.2.2 Safety of the tension-free vaginal tape procedure ................................................... 46 
10.2.3 Surgeon’s experience and safety of the tension-free vaginal tape procedure ......... 47 
10.3 Strengths and limitations ...................................................................................................... 49 
11 Conclusions and implications ................................................................................................... 51 
12 References ................................................................................................................................ 53 
13 Papers ....................................................................................................................................... 65 
14 Appendix ................................................................................................................................... 65 
14.1 Appendix 1: Case Report Form .............................................................................................. 65 
14.2 Appendix 2: Questionnaire from The Norwegian Female Incontinence Registry ................. 65 
14.3 Appendix 3: Ethical approval ................................................................................................. 65 
5 
1 Acknowledgements 
I want to express my gratitude to my main supervisor, Professor Finn Egil Skjeldestad, 
and my co-supervisor, Margareta Verelst, who came up with the idea for this study 
and invited me to participate. Under their leadership, the idea developed into a 
scientific project. I am also grateful to Finn Egil for guiding me through many 
scientific challenges by conveying his knowledge and experience. I would like to 
thank my co-authors, Margareta Verelst, Ian Milsom, and Rune Svenningsen for their 
constructive feedback, as well as express my gratitude to Kajsa Møllersen, who 
contributed the expertise in statistics that was necessary to complete Paper III. The 
implementation of this project would not have been possible without the support of my 
employer; thus I thank Nordland Hospital for its economic and practical support, as 
well as for granting me leave to carry out data collection and attend courses. Special 
thanks is due to the Division for Training, Research, and Development at Nordland 
Hospital, who made it possible for me to take my exam in statistics in Bodø. Finally, I 
extend my gratitude to my beloved daughter, Marte, who provided glossy versions of 
the figures in Paper II. 




EUS External urethral sphincter  
ISD Intrinsic sphincter deficiency 
LAM Levator ani muscle 
MUI Mixed urinary incontinence 
MUS Midurethral sling 
OAB Overactive bladder 
PFMT Pelvic floor muscle training 
SUI Stress urinary incontinence 
TVT Tension-free vaginal tape 
UI Urinary incontinence 
UR Urinary retention 
UUI Urgency urinary incontinence 
VD Voiding dysfunction 
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4 Abstract 
Until the late 1990s, the Burch colposuspension was considered the gold standard for 
the surgical treatment of stress urinary incontinence (SUI) and stress-dominated mixed 
urinary incontinence (MUI) in women. In 1996, Ulmsten introduced the minimally 
invasive retropubic tension-free vaginal tape (TVT) procedure, and the first case series 
reported high safety and effectiveness of this procedure at 2-year follow-up. Despite 
the lack of data showing the superiority of the new method, the TVT procedure 
replaced the Burch colposuspension as the preferred surgical method worldwide 
within a few years.  
We at the Department of Gynaecology at Nordland Hospital, Bodø, Norway, 
introduced the TVT procedure in 1998, and from 2000 onwards we stopped carrying 
out Burch colposuspensions completely. In order to confirm or reject the superiority of 
the new method, we applied data from surgeries performed before, during, and after 
this overlapping time period to compare the long-term treatment effectiveness of both 
surgical methods. In addition, we wanted to present short- and long-term safety and 
effectiveness data and to assess the risk factors for recurrence of SUI symptoms after 
the TVT procedure. Furthermore, the safety of the TVT procedure has been 
questioned, due to reports of serious and debilitating problems among women who 
underwent the procedure to treat urinary incontinence (UI). After the introduction of 
the TVT procedure, the number of women undergoing UI surgery increased rapidly, 
and the quality of this surgical treatment came into focus. We were particularly 
interested in the role of surgeon’s experience on clinical outcomes after TVT surgery.  
The study population comprised 748 primary incontinence surgeries performed at our 
department in the period 1994-2012. In the assessment of clinical outcomes in Paper I, 
we compared the last 5 years of the Burch colposuspension (n = 127, 1994-1999) with 
the first 5 years of the retropubic TVT procedure (n = 180, 1998-2002). In Paper II, we 
assessed long-term clinical outcomes (n = 596, 1998-2012) of the primary TVT 
procedure and performed an analysis of demographic, clinical, and perioperative risk 
factors for treatment failure. Paper III was an assessment of associations between 
surgeon’s experience with the primary retropubic TVT procedure and both 
perioperative complications and recurrence rates. 
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The 3 papers were designed as patient series, and the statistical analyses were done 
using the Statistical Package for the Social Sciences, with a 5% level of statistical 
significance. We applied the t-test, Chi Square test, survival analysis, Cox regression 
analysis, and binary regression analysis. 
In Paper I, we found a significant, higher cumulative SUI symptom recurrence rate at 
12-year follow-up in women who received the Burch colposuspension compared to
those who received the TVT procedure, when pure SUI was used as the indication for 
surgery. However, we did not find any significant difference in treatment effectiveness 
among women who received this procedure for MUI. In Paper II, we found that the 
TVT procedure had a high long‐term durability, and that long-term complications 
were rare. Furthermore, we demonstrated that the TVT procedure was much more 
effective in women with SUI than MUI; the recurrence rate was two-fold higher 
among women with MUI. In Paper III, we observed that patients of surgeons who 
have less experience with the primary TVT procedure showed higher risk of bladder 
perforation and urinary retention, with less impact on long-term recurrence rates. We 
found significant differences in recurrence rates between surgeons, and the differences 
in recurrence rates between women with MUI and SUI were similar for the two 
surgeons who had performed TVT procedures throughout the study period. 
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5 Summary in Norwegian (Sammendrag på norsk) 
Burch kolposuspensjonen var fram til 1990-tallet den anbefalte operasjonsmetoden 
ved kirurgisk behandling av kvinner med stressinkontinens og blandingsinkontinens 
med dominerende stress-komponent. Den minimalt invasive operasjonsmetoden, 
tensjonsfri vaginal tape, ble introdusert av Ulmsten i 1996, og de første pasientseriene 
rapporterte god behandlingseffekt og høy sikkerhet ved to års oppfølgning. Innen få år 
hadde tensjonsfri vaginal tape erstattet Burch kolposuspensjonen som førstevalg i den 
kirurgiske behandlingen av stressinkontinens hos kvinner verden over, selv om ingen 
studier som sammenlignet de to metodene hadde vist noen klar forskjell i 
behandlingseffekt. 
Kvinneklinikken ved Nordlandssykehuset i Bodø, Norge, introduserte tensjonsfri 
vaginal tape i 1998, og fra 2000 av ble det ikke lengre utført Burch kolposuspensjon 
ved vår avdeling. Vi ønsket å sammenligne behandlingseffekten for de to metodene 
ved å bruke oppfølgningsdata fra operasjoner utført i årene før, under og etter denne 
overgangsperioden. Videre ønsket vi å presentere kliniske oppfølgningsdata for 
komplikasjoner og behandlingseffekt samt å finne eventuelle risikofaktorer for 
tilbakefall av stressinkontinens etter tensjonsfri vaginal tape operasjon. Det er blitt satt 
spørsmåltegn ved sikkerheten ved tensjonsfri vaginal tape operasjoner de senere år, 
dette på bakgrunn av rapporter om alvorlige senskader hos kvinner som er blitt operert 
med denne metoden. Siden antall kvinner som ble operert for urinlekkasje økte sterkt i 
årene som fulgte etter at den nye operasjonsmetoden ble lansert, ble det også økt fokus 
på kvaliteten på det kirurgiske behandlingstilbudet. Derfor ønsket vi å se på hvilken 
rolle kirurgens erfaring hadde på resultatene etter tensjonsfri vaginal tape operasjon. 
Studiepopulasjonen utgjorde 748 primæroperasjoner for urinlekkasje utført ved vår 
avdeling i perioden 1994-2012. I Artikkel 1 sammenlignet vi behandlingseffekt og 
komplikasjoner mellom de siste 5 årene med Burch kolposuspensjon (n= 127, 1994-
1999) og de 5 første årene med tensjonsfri vaginal tape (n = 180, 1998-2002). I 
Artikkel 2 presenterte vi tidlige og sene komplikasjoner og behandlingseffekt etter 596 
primære tensjonsfri vaginal tape operasjoner utført i perioden 1998-2012 samt en 
analyse av risikofaktorer for tilbakefall. Artikkel 3 er en analyse av mulig 
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sammenheng mellom kirurgens erfaring og risiko for komplikasjoner og tilbakefall 
etter tensjonsfri vaginal tape operasjon. 
Alle 3 studiene ble utformet som retrospektive pasientserier. Statistiske analyser ble 
gjort med programmet Statistical Package for the Social Sciences med 5% 
signifikansnivå. Det ble anvendt t-test, Chi Square test, survival analyse, Cox 
regresjonsanalyse og binær regresjonsanalyse. 
I Artikkel 1 fant vi blant kvinner som hadde ren stressinkontinens som indikasjon for 
operasjon signifikant høyere risiko for tilbakefall av symptomer på stressinkontinens 
hos de som var operert med Burch kolposuspensjon sammenlignet med tensjonsfri 
vaginal tape opererte kvinner ved oppfølgning inntil 12 år. Derimot var det ingen 
signifikant forskjell i behandlingseffekt mellom metodene blant kvinner som hadde 
blandingsinkontinens som indikasjon for operasjon. I Artikkel 2 fant vi god 
behandlingseffekt og lav risiko for senkomplikasjoner ved oppfølgning inntil 10 år hos 
kvinner operert med tensjonsfri vaginal tape. Videre fant vi at risiko for tilbakefall av 
symptomer på stressinkontinens var dobbelt så høy hos kvinner med 
blandingsinkontinens sammenlignet med kvinner med stressinkontinens som 
indikasjon for operasjon. I Artikkel 3 fant vi at det ved operasjoner der kirurgen hadde 
liten erfaring med tensjonsfri vaginal tape kirurgi var høyere risiko for blæreskade og 
blæretømningsproblemer i etterkant av operasjonen, mens effekten på 
behandlingseffekt ved inntil 10 års oppfølgning var liten eller usikker sammenlignet 
med operasjoner der kirurgen hadde større erfaring med metoden. Vi fant også at det 
var signifikante forskjeller i behandlingseffekt mellom enkeltkirurger, og at 
forskjellene i tilbakefallsfrekvens mellom kvinner med ren stressinkontinens og 
blandingsinkontinens som indikasjon for operasjon var gjennomgående for kirurgene. 
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6 Introduction 
The thesis describes short- and long-term clinical outcomes among women who 
underwent urinary incontinence (UI) surgery at Nordland Hospital in 1994-2012. 
UI is a significant health problem in women, with a prevalence of 25-29% among 
those aged >20 years (1). In addition to the economic costs incurred by patients and 
healthcare services, nearly 60% of affected women perceive their UI to be moderate or 
severe (1). After the introduction of the retropubic tension-free vaginal tape (TVT) 
procedure in 1996 (2), the number of women undergoing midurethral sling (MUS) 
surgery increased rapidly, probably due to both the increasing prevalence of UI (1) and 
the lower threshold for surgery. 
In order to place this topic in perspective  I present an unsystematic review of UI in 
women, including epidemiology, risk factors, pathophysiology, and non-surgical 
treatment followed by a review of the transition from the Marshall-Marchetti-Krantz 
operation, via the Burch colposuspension, to the modern MUS surgical procedures 
used to correct stress UI (SUI) in women. 
6.1 Definitions - Urinary incontinence in women 
It is generally accepted that there are three main types of UI in women; SUI, urgency 
UI (UUI), and mixed UI (MUI). The International Continence Society originally 
defined UI as “…the involuntary loss of urine that is a social or hygienic problem” 
(3). However, this definition only considers complaints related to quality of life. 
Newer definitions take into account symptoms, signs, and clinical and urodynamic 
observations. Furthermore, UI should be described according to relevant, specifying 
factors, such as type, severity, and precipitating factors. Therefore, the International 
Continence Society has presented a newer definition of UI: “…the complaint of any 
involuntary loss of urine…” (3). Newer definitions of the three main types of UI in 
women were presented in a report from the International Continence Society in 2002 
and confirmed in 2010 (3) (4). SUI was defined as “…the complaint of involuntary 
leakage on effort or exertion, or on sneezing or coughing.” UUI was defined as “…the 
complaint of involuntary leakage accompanied by or immediately preceded by 
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urgency.”, and urgency was defined as “…the complaint of a sudden compelling 
desire to pass urine, which is difficult to defer.” (4). Overactive bladder (OAB) is a 
syndrome which is defined by the presence of urgency, with or without UUI, usually 
accompanied by frequency and nocturia without any infection or other obvious 
pathology (4). MUI is “…the complaint of involuntary leakage associated with 
urgency and also with exertion, effort, sneezing or coughing.” (4).  
6.2 Epidemiology and risk factors 
The prevalence of UI among Norwegian women aged >20 years was estimated in the 
EPINCONT 1- and EPINCONT 2-studies (1), which showed an increase in crude 
prevalence from 25.0% in 1995-1997 to 29.0% in 2006-2008 in the same cohort of 
women. The significant change was mainly observed among women aged <50 years. 
In a review by Hunskaar et al. (5), which included 11 studies, SUI was the most 
frequent type of UI in the general female population, comprising 29-75% of cases 
(mean 48%), whereas MUI comprised 14-61% (mean 34%), and UUI 7-33% (mean 
17%). 
There is general agreement that the following risk factors or conditions determine 
incidence and severity of UI in women: age (1) (6), pregnancy (5) (7) (8), parity (9) 
(10) (11), mode of delivery (12) (13), menopause (5) (14) (15), heredity (16) (17), 
previous hysterectomy (10) (11), overweight (18) (19), smoking and other lifestyle 
factors (18) (20), and comorbidities like diabetes (21) (22), depression (10), 
neurological diseases (23) (24) (25), and cognitive dysfunction (26). 
6.3 Urinary incontinence, pelvic floor anatomy, and pathophysiology 
6.3.1 Pelvic floor anatomy and the urethral support system 
The mechanisms of urethral continence are dependent on the urethral support system. 
The structures crucial for this support are the anterior vaginal wall, the endopelvic 




The endopelvic fascia is a strong layer of connective tissue that surrounds the vagina 
and urethra. Laterally, this fascia condensates to the arcus tendineus fasciae pelvis 
(28), a fibrous band anteriorly connected to the posterior surface of the pubic bone 
near the midline, and posteriorly connected to the ischial spine. The arcus tendineus 
fasciae pelvis merges with the LAM and urethra, and thus resists caudal movement of 
the anterior vaginal wall and the urethra during increases in intraabdominal pressure 
(27) (28). The pubourethral ligament is a condensation of the endopelvic fascia with 
insertion on the posterior surface of the pubic bone, the urethra, the anterior vaginal 
wall and the bladder neck, and is hypothesized to play a role in the stabilization of the 
urethra (29) (30). 
 
 
Fig. 1 Muscles in pelvic floor from above (https://antranik.org/) 
 
The inner muscular layer of the pelvic floor (Fig. 1) comprises the left and right LAM 
anteriorly and the coccygeal muscles posteriorly (31). The LAM comprises medially 
the puborectal muscle, pubococcygeal muscle in the intermediate position, and the 
ileococcygeal muscle laterally. The puborectal and pubococcygeal muscles arise from 
the posterior aspect of the pubic bone, insert into the anal sphincter complex, and pass 
behind the rectum and fuses with contralateral counterpart to form a sling. The 
longitudinal muscle of the anus receives fibres from the puborectal muscle, traverses 
through the external anal sphincter, and is inserted in the perianal dermis. The 
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ileococcygeal muscle arises from the arcus tendineus fasciae pelvis. Posteriorly, the 
ileococcygeal and the pubococcygeal muscles insert into the coccygeal bone. The 
ileococcygeal muscle forms a horizontal sheet over the posterior region of the pelvis, 
providing a shelf on which the pelvic organs rest (27).  
 
The inner border of the LAM forms the margin of the levator hiatus, through which 
the urethra, vagina, and rectum pass. The urogenital diaphragm is a musculofascial 
structure that bridges the gap between the inferior rami of the pubic bone below the 
pelvic diaphragm and closes the anterior part of the levator hiatus. The urethra and 
vagina pass through the urogenital diaphragm, thus they have a weak sphincter-like 
effect on the distal vagina; the external urethral sphincter (EUS) is also part of the 
urogenital diaphragm (31). The proximal one-third of the urethra is surrounded by 
striated muscle fibres from the EUS and has an intraabdominal location. In his study 
of the EUS, Wallner described its inferior section as a horseshoe-shaped structure that 
surrounds the lower urethra anteriorly and is inserted in the lateral vaginal wall 





Fig. 2 External urethral 
sphincter (coloured 
blue) from (32), with 
kind permission from 
WH Lamers.  
Fig. 3 Anterior vaginal wall as a “hammock” 
supporting the urethra (pubococcygeal muscle, 
PCM; pubourethral ligament, PUL) from (33), 





6.3.2 The three mechanisms of continence 
 
The mechanism of stress continence is provided by a complex interaction between 
striated and smooth muscles, nerves, connective tissue, and a well-vascularized 
urethral mucosa and submucosa. These structures act together to ensure a higher 
pressure in the urethra than in the bladder in situations with increased intraabdominal 
pressure. The original hypothesized mechanism of stress continence suggested that, by 
descending away from its intraabdominal position, the urethra loses compression 
during straining. This concept was gradually replaced by the ‘hammock hypothesis’ 
(34) (35), which describes the structures that are crucial for the support of urethra and 
the mechanism of continence. The urethra is embedded in the endopelvic fascia; it is 
supported anteriorly by the pubourethral ligaments and posteriorly by the anterior 
vaginal wall. During straining, the urethra is compressed against this hammock-like 
supportive layer, which keeps the lumen closed. The muscles most important for the 
continence mechanism are the strong puborectal muscle and the weak EUS. The 
mechanical effect of the strong puborectal muscle is to pull the anterior urethral wall 
downwards in posterior direction during contraction and thereby stretch the anterior 
vaginal wall into a tympanitic membrane. The effect of the weaker EUS is to close the 
urethra by creating a waterproof seal for the bladder, supported by mucosa, a 
vascularized submucosa, smooth muscle fibres, and connective tissue (32) (36) (Fig. 
3). Portions of the pubococcygeal muscle and the pubourethral ligaments attach to the 
endopelvic fascia in the “vaginal sulcus” between the lower and middle one-third of 
the anterior vaginal wall, and produce elevation anteriorly of the mid-urethra during 
contraction. A tendinous connection between the LAM and the EUS provides an 
anterior bending of the mid-urethra during simultaneous contraction of the LAM and 
the EUS, which is assumed to be critical to the mechanism of stress continence (37). 
The integral theory of Petros and Ulmsten describes this as the first out of three 
closure mechanisms (34). 
 
The second closure mechanism is the closure of the bladder neck, which is 
performed through a complex interaction between the pubococcygeal muscle and the 
longitudinal muscle of the anus. This action closes the most proximal portion of 
urethra and is dependent on the elastic properties of the vaginal wall and its supporting 
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structures; most importantly the utero-sacral and the cardinal-ligaments, as well as the 
pubourethral and pubocervical ligaments.  
 
During this action, contraction of the levator plate stretches the upper two-thirds of the 
vagina and the pubococcygeal muscle into a semirigid structure; by the contraction of 
the longitudinal muscle of the anus, the pubococcygeal muscle rotates downwards like 
a trapdoor against the urethra. During the same action, the bladder rotates downwards 
and backwards, stretching the bladder neck, which elongates and closes the proximal 
and most flexible portion of the urethra.  
 
As the two first closure mechanisms are involuntarily actions dependent on the central 
nervous system (27). The third mechanism is a voluntary action not normally 
involved in bladder neck closure; therefore it requires training through pelvic floor 
exercises. In nulliparous women, the lower one-third of vagina is oriented more 
vertically and the upper two-thirds more horizontally when compared to multiparous 
women. This is due to the posterior attachments of the cervix provided by the cardinal 
and sacrouterine ligaments, and to the anterior position of the levator hiatus provided 
by the tension of the pubococcygeal muscle. During strain, the levator hiatus is 
shortened by the action of the LAM, and this compression of the pelvic organs in 
forward and upper direction provides support to the bladder neck and the “hammock” 
mechanism, thus comprising the voluntary third closure mechanism (32) (34) (37). 
 
6.3.3 Mechanisms of stress urinary incontinence 
 
The previous section outlines why the ability to stretch and stiffen the vaginal wall, 
i.e., “the hammock“, is crucial for the reflexive closure of the urethral lumen in the 
presence of increasing intraabdominal pressure. Both the Burch colposuspension and 
the TVT procedure aim to provide urethral support by creating a firm fulcrum for the 
forces applied by the pelvic floor muscles. Deterioration of urethral support by 
displacement of the vaginal wall following injury to its normal intrapelvic attachments 




The structures responsible for stress continence may be damaged during pregnancy 
and delivery. The pudendal nerve innervating the EUS can be damaged during 
vaginal delivery; the mechanism is assumed to be ischemia due to either stretch or 
compression (38). The cardinal and sacrouterine ligaments may be stretched or torn 
during pregnancy and delivery resulting in an anterior displacement of the uterus (37). 
Magnetic resonance imaging examination of women with SUI has shown damage to 
the pubourethral ligaments (39). Vaginal injuries can be detected by ultrasonographic 
examination (40). Damage of the LAM due to stretching, tearing, and avulsion results 
in a wider levator hiatus, which reduces the support of pelvic organs like the urethra 
and bladder. An increase in the levator hiatus and loss of the posterior urethro-
vesical angle are strongly associated with urodynamic and clinical stress parameters 
(41) (42). 
 
Changes in connective tissue have been proposed as an aetiological factor for SUI in 
several studies. Ulmsten et al. (43) reported a 40% lower collagen content in biopsies 
from the skin and ligamentum rotundum in women with SUI compared to continent 
women, which suggests an increased laxity in the pelvic connective tissue that could 
lead to reduced vaginal support of the urethra and the bladder base.  
 
Falconer et al. (44) found different collagen properties in paraurethral tissue from 
women with SUI compared to matched continent controls, including a higher 
concentration of collagen and larger collagen fibrils in biopsies from women with SUI. 
These changes were hypothesised to result in a more rigid extracellular matrix, which 
was proposed to deteriorate the mechanical properties of connective tissue. Some 
studies have proposed that these metabolic changes in collagen may have a genetic 
origin (43) (44). 
 
A review by Chen & Yeh (45) presents current knowledge from epidemiological data 
and studies of human tissue and animal models about connective tissue metabolism in 
the genitourinary organs. Data on collagen and elastin metabolism support the 
hypothesis of abnormal elastin metabolism and increased turnover of collagen with 
abnormal extracellular matrix remodelling. All these processes contribute to the 
alteration of normal tissue architecture, to the mechanical properties of pelvic 
connective tissue, and to SUI and pelvic organ prolapse. They can be explained by 
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genetic predisposition and are influenced by reproductive hormones, trauma, 
mechanical stress, and aging.  
 
The second, generally accepted cause of SUI is either loss of support, resulting in a 
reduced urethro-vesical angle, or an intrinsic sphincter deficiency (ISD). It is assumed 
that ISD is due to factors independent of urethral support, i.e., deteriorated function of 
the pudendal nerve, EUS, urethral smooth muscle, mucosa, and submucosa. ISD has 
been equated with a “low pressure urethra” and is clinically defined as a subgroup of 
women with SUI at high risk of failure after surgical treatment (46). Age has been 
shown to be a risk factor for ISD, and age-dependent reduction in muscle mass in the 
EUS has been proposed as an aetiological factor (47) (48) (49).  
 
Clinically, a reduced urethro-vesical angle results in a hypermobile urethra, and ISD is 
characterised urodynamically by low maximal urethral closure pressure (37). 
However, this dichotomy has gradually been replaced by a continuum, due to a 
growing clinical impression that both ISD and hypermobility may exist in patients 
with SUI (37) (46) (50). 
 
6.3.4 Mixed urinary incontinence 
 
The differences in the mechanisms of SUI and MUI are not fully understood. 
According to Brucker, two main theories are used to explain the pathophysiology of 
MUI. The “two pathway” theory defines the stress and urgency components as two 
distinct entities – with UUI being a neurogenic bladder dysfunction and SUI a bladder 
outlet dysfunction due to an insufficient pelvic floor – that require different treatment 
approaches. The alternative “common pathway” theory assumes that leakage of urine 
to the proximal urethra activates the detrusor reflex, providing an explanation for the 
improvement in UUI experienced by many patients with MUI after incontinence 
surgery (51). This indicates a more complex pathophysiology, as well as a more 




6.3.5 Overactive bladder 
 
Symptoms of OAB are suggestive of detrusor overactivity during the filling phase, but 
only about 50% of patients with detrusor overactivity have urgency, and about 50% of 
patients with urgency have demonstrable detrusor overactivity at cystometry (37). 
Cerebral, spinal, and peripheral nerve signalling is involved in the regulation of the 
detrusor function, as well as a complex system of cells, nerves, mediators, and 
receptors in the bladder. The aetiology of OAB is multifactorial and may involve any 
of these structures (52). However, the pathogenesis of UUI is poorly understood.  
 
6.4 Non-surgical treatment of stress urinary incontinence – pelvic floor 
muscle training 
 
Pelvic floor muscle training (PFMT) is a programme that trains the pelvic floor 
muscles by repeated contractions and relaxations under the supervision of a health 
professional, usually a physiotherapist. PFMT is recommended in both the prevention 
and treatment of SUI and MUI (53). Voluntary contractions of the LAM elevate the 
pelvic viscera upwards and forward giving support to the mechanisms that provide 
closure of the urethra, described in the third closure mechanism in the integral theory 
of Petros and Ulmsten (34). Ultrasonograpic and magnetic resonance imaging studies 
have confirmed this movement of the LAM during active contraction, as well as 
changes in the position of the urethra (54) (55). Studies that investigated magnetic 
resonance imaging before and after a PFMT programme revealed a reduction in the 
levator hiatus area, as well as improved urethra stability during rest and effort (56) 
(57).  
 
There is good evidence for the short-term effectiveness of PFMT, but its long-term 
effectiveness has been questioned. A Cochrane systematic review, including 31 trials 
and 1817 women with SUI, MUI, or UUI, assessed PFMT versus no treatment, 
placebo, or sham (inactive) electrical stimulation (58). The results showed an 
association between PFMT and cure and improvement in women with SUI and any 
type of UI when compared to inactive control treatment, but follow-up data beyond 1 
year was lacking. Few studies have assessed the long-term effectiveness of PFMT 
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without incentives for continued training. In the review by Bø et al., which included 
19 trials and 1141 women, the heterogeneity across studies made a statistical meta-
analysis impossible (59). Follow-up varied between 1 and 15 years, and in most of the 
studies, the outcome was assessed by self-administered questionnaires. Long-term 
success rates varied between 41% and 85%, and surgery rates between 4.9% and 58%. 
The effect of PFMT during pregnancy and the early postpartum period was assessed in 
a Cochrane review by Woodley et al. (60). The available data suggested that prenatal 
PFMT may be effective in the prevention of UI in continent women, but not in the 
treatment of incontinent women in late pregnancy or in the early postpartum period 
(up to 6 months postpartum). PFMT may have an effect on a mixed population of 
continent and incontinent women during pregnancy and up to 6 months postpartum. 
PFMT also seems to be effective in elderly women (61). The only study comparing 
PFMT and surgery found surgery to be superior (62). 
 
6.5 Surgical treatment of stress urinary incontinence 
 
Over the years, more than 120 surgical procedures have been applied in the treatment 
of SUI (34), reflecting that none of them is a perfect treatment modality. Urethral 
bulking agents in the treatment of SUI were described as early as 1904, when injection 
with paraffin was shown to cure UI (63). In 1907, Giordano proposed the use of the 
gracilis-muscle to form a hammock underneath the bladder neck and proximal urethra, 
thus introducing the first pubovaginal sling (64). Kelly and Dumm’s publication from 
1914 described performing a plication of the pubocervical fascia on either side of the 
bladder neck, combined with a colporhaphia anterior as treatment for SUI (65). The 
intention was to give support to the “relaxed tissues at the bladder neck”. In 1937, the 
method was modified by Kennedy (66), and named the Kelly-Kennedy plication (67). 
 
6.5.1 Retropubic bladder neck suspension - the Marshall-Marchetti-Krantz procedure 
and the Burch colposuspension 
 
The first Marshall-Marchetti-Krantz procedure on a female was performed on 8 June 
1944 (68) and described in 1949 (69) (Fig. 4). The Marshall-Marchetti-Krantz 
procedure is an open retropubic bladder neck suspension involving fixation of the 
22 
 
bladder neck by suturation of periurethral tissue to the cartilage or periosteum of the 
pubic bone near the midline. A review of 56 articles assessing the clinical outcome of 
this procedure showed an overall success rate of 86.1%, varying between 92.1% for 
primary procedures and 84.5% for repeat procedures, and an overall rate of 
complications of 21.1% (70). However, long-term effectiveness was not reported in 
this review. A special complication of this procedure was infection in the pubic bone, 
with an estimated rate of 2.5% in this review. 
 
 
Fig. 4 Marshall-Marchetti-Krantz 
procedure (71) 




John C. Burch proposed a modification to the Marshall-Marchetti-Krantz procedure in 
1961 (72), as he had identified some problems: “the field is often deep and bloody, the 
edges of the urethra are difficult to define, and the periosteum on the posterior aspect 
of the symphysis is far from ideal as an anchoring structure”. He showed that the more 
laterally located Cooper’s ligament was a more appropriate place for fixation of the 
sutures, thus resolving the problems with the pubic bone (Fig. 5). Burch published a 
patient series of 169 patients with a failure rate of only 7% and a rate of enterocele of 
7.6%. Three trials comparing the effectiveness of the Burch colposuspension and the 
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Marshall-Marchetti-Krantz procedure at 6-12 months reported average cure rates of 
87.9% and 80.3%, respectively. 
 
A modification of the Burch colposuspension was introduced by Tanagho in 1976 
(73): he placed his two sutures far laterally and emphasised the importance of not 
lifting of the vaginal wall too much in order to avoid problems with bladder emptying. 
Despite some studies reporting notable high total rates of complications after Burch 
colposuspension (74) (75), the procedure became the gold standard in the primary 
surgical treatment of female SUI until the TVT was introduced in the late 1990s. The 
subjective cure rates after the Burch colposuspension varied between 44% and 80%, 
and objective cure rates between 67% and 82% in studies with 5-10 years of follow-
up. However, effectiveness appeared to decrease with time (76) (77) (78) (79) (80). 
Furthermore, as some studies reported a detrusor overactivity of rate up to 18% after 
bladder neck elevation surgery (81) (82), caution with this type of procedure in 
patients with urodynamically diagnosed detrusor overactivity was recommended (82) 
(83). 
 
6.5.2 The modern midurethral sling 
 
The development of the modern MUS was preceded by a better understanding of the 
mechanism of incontinence, which occurred simultaneously with an improvement in 
the diagnostic tools, i.e., better radiologic and ultrasonographic methods to explore 
pelvic anatomy, and more advanced urodynamic equipment to assess urinary tract 
physiology. There was a gradual change in focus from stabilisation and especially 
elevation of the bladder neck to support of the mid-urethra. The former way of 
thinking was founded on the hypothesis that the urethra, by descending from its 
intraabdominal position, loses transmission of intraabdominal pressure during 
straining (35) (37). The introduction of the ‘hammock hypothesis’, especially the 
integral theory of Petros and Ulmsten in 1990 (34), was preceded by research that 
revealed the role of the mechanisms of support of the mid-urethra (84) (85) (86). 
Although the integral theory has been questioned in recent years (87), mainly due to 
the absence of prospective clinical trials that support the theory, it represented a 
breakthrough in a process that eventually led to the introduction of the modern MUS. 
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Ulmsten and Petros introduced the intravaginal sling procedure in 1995 (81) (88). 
However, it was abandoned due to tissue reaction to Gore-tex and mersilene tapes in 
8-10% of patients. Finally, Ulmsten introduced the retropubic TVT procedure in 1996, 
a minimally invasive surgical method performed on 75 women with genuine SUI (2). 
For this procedure, a polypropylene tape, covered by a plastic sheath which is 
removed after placement, was applied with a trocar. The trocar was obliquely guided 
through a small suburethral incision approximately 0.5 cm from the external urethral 
meatus, perforating the urogenital diaphragm on each side of the urethra, subsequently 
“shaving” the back of the pubic bone and eventually perforating the abdominal skin 2 
cm bilateral of the midline above the symphysis. The plastic sheath assured that the 
sling did not become contaminated and enabled the sling to be pulled through the 
tissue without friction and trauma. Cystoscopy was performed to preclude bladder 
injury, and the tape was adjusted by means of a coughing test. In his first patient 
series, Ulmsten performed the procedure using local anaesthesia, and released the 
patients from the hospital the day of the procedure or the day after, granting a sick 
leave of 10 days. The mean operation time was 22 minutes, and no serious 
complications occurred, nor were there any tape rejections after a follow-up period of 
2 years. 84% of women were cured, and another 8% improved significantly. 
Polypropylene had been used for years for abdominal hernia repair, and had shown 
inert qualities. Moreover, the Ulmsten team discovered a cut-off for pore size, which 




7 Background for the study and aims of the thesis 
 
7.1 Transition from the Burch colposuspension to the retropubic tension-
free vaginal tape procedure 
 
While the Burch colposuspension is an inpatient surgical procedure requiring general 
or regional anaesthesia, the TVT procedure is a minimally invasive outpatient 
procedure. Several studies showed high safety and effectiveness of the TVT procedure 
after 2 years of follow-up (2) (89) (90). Although no studies have proven the TVT 
procedure to be superior to the Burch colposuspension, within a few years, the 
retropubic TVT procedure replaced the Burch colposuspension as the gold standard in 
the primary surgical treatment of SUI and stress-dominated MUI in women. However, 
until 2005, neither randomised controlled trials nor meta-analyses had revealed any 
significant differences in effectiveness at 5-year follow-up in favour of the TVT 
procedure (91) (92). 
 
7.2 Effectiveness of the retropubic tension-free vaginal tape procedure 
 
To-date, numerous publications have shown a high long-term effectiveness of the TVT 
procedure. However, cure rates depend on patient selection; exclusion of women with 
MUI, and/or earlier or concomitant pelvic floor surgery. Subjective cure rates of 77-
90% have been shown 10-11 years after primary TVT surgery among women with 
SUI (93) (94), whereas primary TVT surgery on populations comprising women with 
both SUI and MUI have subjective long-term cure rates of 75-80% (95) (96). Studies 
assessing the TVT procedure in patient populations that include women with earlier UI 
or prolapse surgery and concomitant prolapse surgery show subjective cure rates of 
65-76% (97) (98); even lower cure rates (37-55%) are reported for women with MUI 
(99) (100). 
 
MUI is the most consistently reported risk factor for recurrence after the TVT 
procedure (99) (100) (101). Furthermore, age, overweight, and diabetes mellitus have 
also been reported as risk factors in some studies (95) (99) (101) (102). Two studies 
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reported perioperative complications as a predictive factor for cure failure (101) (102). 
However, most long-term follow-up studies did not have sample sizes large enough 
for risk factor analyses (93) (95) (97). 
 
7.3 Safety of the tension-free vaginal tape procedure 
 
In recent years, the safety of TVT surgery has been questioned. A report from the UK 
Medicines and Healthcare Products Regulatory Agency concluded that “Women have 
reported serious and debilitating problems following surgical treatment for SUI 
vaginal tape implants” (103). A 2015 editorial from the Cochrane Library summarised 
20 years of experience with surgical treatment of UI in women, and questioned the 
fact that only a few of the 35 trials that reported on long-term follow-up observed 
leakage and adverse effects 5 years or more after treatment (104). The authors also 
stated that more evidence was needed about the safety of new methods in comparison 
to older, abandoned methods (104). 
 
The most frequent late complication of MUS surgery is de novo OAB in women with 
SUI, with a rate of de novo UUI of 15% (98) (100). Erosion is the most frequent late 
tape complication, with rates of 0-4.2% (98) (105) (106) (107) (108). 
 
7.4 The importance of surgeon’s experience in the clinical outcomes of 
the tension-free vaginal tape procedure 
 
To date, numerous studies have assessed the demographic and clinical risk factors for 
adverse outcomes after TVT surgery. However, studies assessing the role of surgeon’s 
experience in this context have mostly focused on perioperative complications (109) 
(110) (111). Existing evidence has shown an increased risk of bladder perforation 
when the surgeon is a ‘beginner’ (112) (113) (114) (115) (116). The decreasing rate of 
bladder perforation with increasing number of procedures performed has been defined 
as a possible measure of surgeon’s experience (111). However, very different cut-off 
values have been applied to test this experience, from <16, <30, <50, or <100 
surgeries (111) (112) (115). The literature is also inconclusive regarding the duration 
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of surgeon’s learning phase when studying urinary retention (UR) (114) (117) and 
other perioperative complications (105) (109) (110) (118) (119). Moreover, few 
studies have looked at long-term effectiveness (102) (105) (120) (121), and most of 
these studies had low sample sizes (<500). At 2- and 4-year follow-up, two studies 
reported reduced cure rates in low- versus high-volume departments and when 
comparing low- versus high-volume TVT surgeons (120) (121). 
 
Surgeon’s experience is usually characterised by the number of TVT procedures 
performed and/or by the surgeon’s position in the department (senior 
consultant/resident), while the institutions are described by their organisational level 
(university, central or local hospital, teaching/non-teaching hospital) and/or annual 
surgery volume. 
7.5 Aims of the thesis  
 
We at the Department of Gynaecology at Nordland Hospital in Bodø, Norway, 
introduced the TVT procedure in 1998, and from 2000 onwards we stopped carrying 
out Burch colposuspensions completely. In order to confirm or reject the superiority of 
the new method, we applied data from surgeries performed before, during, and after 
this overlapping time period to compare the long-term treatment effectiveness of both 
surgical methods. In case of confirmation of the TVT procedure as the “gold 
standard”, we wanted to perform a further assessment of the TVT procedure with 
respect to clinical outcomes at long-term follow-up and a risk factor analysis. Other 
studies have identified groups of patients with lower expectations for cure following 
the TVT procedure, and we were particularly interested in identifying risk factors for 
treatment failure in our data. Furthermore, the safety of the TVT procedure has been 
questioned recent years due to reports of serious and debilitating problems among 
women who received the TVT procedure to treat UI. After the introduction of the TVT 
procedure, the number of women undergoing UI surgery increased rapidly, and the 
quality of this surgical treatment came into focus. We were particularly interested in 
identifying factors which may improve the quality of the treatment, and we performed 
an assessment of the role of surgeon’s experience on clinical outcomes following the 




 The aims of Paper I were to compare short- and long-term clinical outcomes in 
women undergoing the Burch colposuspension and the retropubic TVT 
procedure. 
 The aims of Paper II were to investigate clinical long-term outcomes and to 
assess demographic, clinical, and perioperative risk factors for recurrence 
within 10 years of a primary retropubic TVT procedure. 
 The aims of Paper III were to assess the associations between surgeon’s 
experience and 1) perioperative complications and 2) recurrence rates in 




8 Materials and methods 
 
8.1 Study design 
 
The studies were performed as consecutive, retrospective case-series. 
 
8.2 Study population 
 
The study population comprised women who received surgery for UI at The 
Department of Gynaecology, Nordland Hospital, Bodø, Norway in the period 1994-
2012. In order to find all such cases (case ascertainment), we searched the hospital’s 
patient administrative system for patients with a diagnosis of UI according to the 
International Classification of Diseases versions 9 and 10 (ICD 9 and 10), as well as 
those with registered UI-related surgical procedures (Table 1) according to the 
Norwegian system for classification of surgical procedures, 2nd and 3rd edition for the 
period 1994-1998, and to the Nordic Medico-Statistical Committee Classification of 




Table 1 Codes used to identify cases with a diagnosis of urinary incontinence or with registered urinary 
incontinence-related surgical procedures  
Abbreviations: ICD 9/10: International Classification of Diseases versions 9 and 10, NSCP: Nordic Medico-
Statistical Committee Classification of Surgical procedures. 
  
We identified 895 women who had undergone a UI-related surgical procedure during 
the study period (Fig.6). We excluded women operated with: Burch colposuspension 
on solely prolapse indication, past pelvic surgery of prolapse and/or incontinence, 
concomitant prolapse surgery, primary incontinence surgery other than open Burch 





ICD-9 ICD-10 Denomination 
Urinary 
incontinence 
625.6 N39.3 Stress incontinence 
788.3 N39.4 Other specified urinary 
incontinence 
788.4 N39.8 Other specified disorders of 
urinary system 




Norwegian system for 
classification of surgical 
procedures, 2nd and 3rd 
edition 
NSCP   
Urinary 
incontinence 
747 LEG 00 Vaginal urethrocystorrhaphy 
(Kelly-Kennedy, etc.)  
7471 LEG 10 Vaginal urethrocystopexy with 
use of sling 
 LEG13 Vaginal transobturatorial 
urethropexy 
7471 KDG 96 Other operation on urethra or 
bladder neck for incontinence  
 KDV22 Transluminal endoscopic 
submucous urethral injection 
(Zuidex, Bulkamid) 
6356 KDG 00 Retropubic suspension of 
urethra (Marshall-Marchetti-
Krantz) 
6356 KDG 20 Abdominal colposuspension 
(Burch) 
6355 KDG 30 Suprapubic sling 
urethrocystopexy 
7479 LEG 96 Other vaginal operation for 
incontinence 
Period 1994-1998 1999-2012  
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Abbreviations: TVT, tension-free vaginal tape. 
Eligible patients  (n = 895) 
Burch colposuspension due to 
prolapse (n = 26) 
Previous pelvic floor surgery 
(n = 60) 
 Urinary incontinence (n = 28)
 Prolapse  (n = 24)
 Concomitant urinary
incontinence and prolapse
surgery (n = 8)
Concomitant prolapse surgery 
(n = 5) 
Primary incontinence 
surgeries other than TVT 
(n = 183) 
 Open Burch colposuspension
(n = 127)
 Laparoscopically performed
Burch colposuspension (n = 42)
 Others (n = 14)
Primary TVT procedure (n = 596) 
Number of TVT procedures 
(n = 697) 
TVT (n = 39) 
TVT (n = 3) 
No follow-up data (n = 25) 
Primary TVT procedures 
 (n = 621) 
Repeat TVT 
procedure 




(n = 27)  
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The final study sample comprised 127 women who received the Burch 
colposuspension and 621 women who received the TVT procedure as primary surgery 
for SUI or MUI. We performed the Burch colposuspension as originally described by 
Tanagho (73), and the TVT procedures were performed as described by Ulmsten (2).
All women treated with the TVT procedure received prophylactic antibiotics, and we 
used surgical kits from Johnson & Johnson. 
In Paper I, we restricted the study sample to women who underwent primary UI 
surgery during the last 5 years of the Burch colposuspension (n = 127, 1994-1999) and 
the first 5 years of the TVT procedure (n = 180, 1998-2002), in total 307 women. 
In Paper II, we excluded 25 women with no follow-up data, thus the final study 
sample comprised 596 women who underwent a TVT procedure as primary surgery 
for SUI or stress-dominated MUI in 1998-2012. 
In Paper III, we applied the same study population as in Paper II to assess 
perioperative complications by surgeon’s experience. In the assessment of recurrence 
by surgeon’s experience, we restricted the analyses to the three surgeons who had 
performed >50 primary TVTs; combined, they had performed 494 surgeries. 
8.3 Data collection 
We made the first draft of the study protocol in 2013 and updated it as necessary. Data 
collection took place in 2014-2015. The electronic medical records were screened 
retrospectively and the information transferred to a case report form that was 
especially designed for the study (Appendix 1). For patients referred for primary UI 
surgery from neighbouring hospitals (n = 166), the medical records were examined 
during follow-up at relevant local hospitals in our region (Nordland County) as well. 
Data sources included referrals from general practitioners, private gynaecologists, and 
gynaecologist at local hospitals; discharge summaries from hospitalisations and visits 
at the outpatient clinic of the gynaecological department as well as other departments; 
validated questionnaires (from 2002 onwards); forms with data on frequency and 
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volume of urination that were completed by patients; clinical tests; operative reports; 
and anaesthesia records. All data was interpreted, systematised, and transferred to the 
case report form. 
The preoperative evaluation comprised a stress test, assessment of bladder emptying, 
and cystometry. For stress tests in the early period, patients were asked to cough in a 
supine position with 300 ml of saline in the bladder (122). From 2004 onwards, we 
also performed a coughing test in an upright position with 300 ml saline in the bladder 
and a registration of pad weight before and after three forceful coughs and 20 sideway 
split jumps (123). Furthermore, we performed cystometry in patients with symptoms 
of OAB. Voiding function was assessed by measurement of residual urine (ml) and 
uroflowmetry analysis (including description of the shape of the curve and the 
estimate of maximum flow rate (<15 ml/s or ≥15 ml/s)) (124). 
8.3.1 Demographic and pre-, peri-, and postoperative variables 
The following preoperative data were included: type of UI (SUI/MUI), age at time of 
surgery (≤49, 50-59, ≥60 years), parity (0-1, 2, ≥3), menopausal status 
(premenopausal, perimenopausal, postmenopausal, Paper I only), body mass index, 
past hysterectomy (total and subtotal) and relevant comorbidities (cardiovascular 
disease/diabetes (0/1), pulmonary disease (0/1), and neurological disease (0/1)). The 
following information was collected during the preoperative examination: previous 
conservative treatment for UI (PFMT and electrical stimulation), uroflowmetry 
assessments (including the shape of the curve and the estimated maximum flow rate 
(<15 ml/s or ≥15 ml/s)). In addition, the results from two standardised stress tests 
(coughing with 300 ml saline in the urinary bladder in supine and/or upright position 
and/or pad weight before and after three forceful coughs and 20 sideway split jumps) 
and measurement of residual urine (ml) were included (122) (123). Date and type of 
UI surgery were also recorded, as were type of perioperative complications, date and 
type of surgery for perioperative complications, date of first visit for complication 
symptoms, type of late complication, and date and type of surgery for possible late 
complications. Finally, date of first visit for recurrence symptoms, date and type of 
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repeat UI surgery, date and type of urinary symptoms at last visit (including no 
symptoms), and date of possible prolapse surgery following UI surgery were recorded. 
After the collection of the clinical data from 697 TVT procedures performed in 1998-
2012, the names of the surgeons were coded in a separate file linked to the identity of 
the women on whom they operated. Data on surgeons were retrieved from the 
hospital’s patient administrative system. Among the surgeons who performed the 596 
primary TVT procedures included in the study sample, 18 had the status of lead 
surgeon (Table 2). Two surgeons operated continuously and performed more than two-
thirds of the primary TVT procedures (surgeon A: n = 190, surgeon B: n = 237), while 
a third surgeon did 67 primary TVT procedures during the first 5 years of the study 
period (surgeon C). The remaining 15 surgeons performed 102 primary TVT 
procedures, varying from one to 32, mainly before 2007, and they comprised surgeon 
group D. While surgeons A, B, and C were specialists in gynaecology and obstetrics 
when they started to perform the TVT procedure in 1998, surgeon group D comprised 
experienced residents approaching their licensure as gynaecologists and experienced 
senior consultants who had performed the TVT procedure at other hospitals. 
Table 2 Annual number of tension-free vaginal tape procedures by surgeon and calendar year 
Surgeon 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total 
A 5 8 8 4 1 7 10 19 11 13 12 26 32 26 8 190 
B 1 10 13 14 4 8 13 4 19 20 28 28 30 25 20 237 
C 6 19 19 17 6 0 0 0 0 0 0 0 0 0 0 67 
E 0 0 0 1 8 8 8 5 2 0 0 0 0 0 0 32 
F 0 0 0 2 3 6 0 6 2 0 0 0 0 0 0 19 
G 0 0 0 0 1 3 6 1 0 0 0 0 0 0 0 11 
H 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 8 
I 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 8 
J 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 5 
K 0 0 4 1 0 0 0 0 0 0 0 0 0 0 0 5 
L 0 1 0 2 1 0 0 0 0 0 0 0 0 0 0 4 
M 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 
N 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 2 
R 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 
Q 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
S 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 
T 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 
V 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 
Total 19 48 44 42 24 32 39 37 35 33 40 54 62 51 36 596 
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8.4 Definitions 
8.4.1 Type of urinary incontinence 
The classification of type of incontinence was based on a combination of symptoms 
documented in medical records, outcome of stress tests and/or urodynamic 
examinations, and a standardised, validated, short-form UI disease-specific 
questionnaire used from 2002 onwards (125). We defined SUI as bothersome 
symptoms of SUI described in the medical record and/or in the standardised 
questionnaire in combination with a positive stress test. MUI was defined as a 
combination of a dominant SUI component and UUI defined as a description of 
bothersome symptoms of involuntary urine leakage after sudden urgency to void in the 
medical record and/or in the standardised questionnaire. Positive cystometry was not 
mandatory for a diagnosis. 
8.4.2 Recurrence of urinary incontinence 
We defined recurrence of UI as the presence of any bothersome, patient-reported 
symptoms of SUI; a SUI index score >0 indicative of bothersome symptoms of SUI on 
a validated questionnaire (125); or a positive standardised cough/jump pad stress test 
(123). Neither de novo UUI in women with pure SUI before UI surgery, nor 
recurrence of UUI in women with preoperative MUI was defined as recurrence. New 
evaluation with stress test and/or uroflowmetry analysis was performed according to 
individual clinical assessment of severity and type of complaints, especially if repeat 
surgery was an option. As most of the data were based on women’s subjective 
description of symptoms, treatment effectiveness in this study largely reflected 
subjective cure. 
8.4.3 Complications 
Apart from voiding dysfunction (VD), different complications occurred in the 
perioperative period compared to weeks or months later. As most problems regarding 
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voiding function resolve spontaneously within a few days, we chose not to include 
need of catheterisation within 1 week of surgery as a complication. However, a few 
patients reported need of catheterisation several months after surgery. Due to a shorter 
hospital stay after the introduction of the TVT procedure and the use of antibiotic 
prophylaxis, it is possible that some urinary infections were diagnosed and treated by 
general practitioners after discharge, and therefore are not captured in our data. As we 
expected underreporting of urinary infections and lower incidence of urinary 
infections among women who received the TVT procedure, we decided not to include 
uncomplicated urinary infections among perioperative or late complications. 
Complications are listed and defined more in detail in Table 3. 
Table 3 Definition of complications 
Type Paper I Papers II and III 
Perioperative 
complications 




Need of catheterisation for 1 week or 
more 
Need for catheterisation more than 1 
week after primary surgery and/or in 
need of traction and/or surgical 
correction necessitating cutting of the 
tape 
Bleeding/hematoma Surgeon’s description of significant 
bleeding intraoperatively and/or 
clinical significant and/or 
ultrasonographically identified 
hematoma of any size 
Clinically significant and/or 
ultrasonographically identified 
hematoma of any size 
Other complications Anaesthesiological complications, 
surgical site infections, removal of the 
tape in those who underwent the 
tension-free vaginal tape procedure, 
etc. 
Anaesthesiological complications, 
surgical site infections, removal of the 
tape in those who underwent the 





De novo urgency or de novo urgency 
urinary incontinence in women with 




Permanent need of catheterisation 
Tape 
complications 
Symptomatic or asymptomatic 
erosions, fistulas, and symptoms of 
dyspareunia and/or chronic 
pain/discomfort diagnosed three 
months or later after primary surgery 
Symptomatic or asymptomatic 
erosions, fistulas, and symptoms of 
dyspareunia and/or chronic 
pain/discomfort diagnosed three 
months or later after primary surgery 
(Paper II only) 
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8.4.4 Follow-up 
All patients who underwent surgery in 1994-2008 were invited to a follow-up visit 
after 6-12 months. Follow-up included an interview and clinical examination, followed 
by urodynamics if bothersome symptoms were present. In the interview, the women 
were asked about their satisfaction with the treatment, and from 2002 onwards the 
department used a standardised questionnaire including the categories “very satisfied”, 
“satisfied”, “neither satisfied nor dissatisfied”, “dissatisfied”, and “very dissatisfied”. 
For patients residing far from our hospital, we performed the interview by phone or by 
postal questionnaire. From 2009 onwards, the first follow-up was performed by means 
of a standardised questionnaire by post or phone, and the patients were offered a visit 
at the outpatient clinic if bothersome symptoms were present. 
The department introduced a standardised 3-year follow-up using the validated short-
form UI disease-specific questionnaire for women who underwent surgery from 2009 
onwards (Appendix 2). All other follow-up data were retrieved from consultations at 
our outpatient clinic after referral from general practitioners or private gynaecologists. 
For patients not residing in our hospital’s local catchment area, we retrieved follow-up 
data from medical records at the local hospitals throughout our region. 
Medical records were screened through 1 November 2015. 
8.4.5 Main exposure and outcomes 
The main exposure, and primary and secondary outcomes are presented in Table 4. 
Recurrence of SUI was a primary outcome, and due to a shorter average observation 
time in Papers II and III, we restricted the follow-up to 10 years in these papers. 
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Table 4 Main exposure, and primary and secondary outcomes 
Paper I Paper II Paper III 
Main exposure Surgical procedure (Burch 
colposuspension, retropubic 
tension-free vaginal tape) 







Recurrence Recurrence Recurrence 
Secondary 
outcomes 
Perioperative complications Urinary retention and other 
perioperative 
complications  
Urinary retention and other 
perioperative 
complications  
Late complications Late complications 
8.5 Statistical analysis 
I performed all statistical analyses, save the analyses of recurrence rates by surgeon’s 
experience in Paper III, and used the Statistical Package for the Social Sciences 
version 25 (IBM, Armonk, NY, USA).  
Analyses of recurrence rates by surgeon’s experience in Paper III were performed by a 
postdoctoral student, Kajsa Møllersen, with MatLab version 2019a. 
Statistical significance was set to a 5% level. 
The data were analysed with the t-test, Chi-squared test, survival analysis, Cox 
regression analysis, and binary logistic regression analysis. 
The Chi-squared test was applied in the assessment of preoperative data (baseline 
characteristics, conservative treatment, and clinical examinations), perioperative data 
(complications, hospital stay), follow-up data, and rates of repeat surgery by study 
group (Burch group versus TVT group, women with SUI versus MUI, surgeon and 
surgeon experience group (1-19 (‘beginner’), 20-49, and ≥50 primary TVT procedures 
performed)).  
Survival analysis was applied in order to analyse duration of time from the exposure 
(surgery) to the event of interest (recurrence, late complication, repeat surgery due to 
recurrence or prolapse). Furthermore, survival analysis (life tables) was applied when 
estimating cumulative cure rates of TVT, and Cox regression analysis was applied in 
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the risk factor analysis of recurrence. In the survival and Cox regression analyses, only 
cases (recurrences, late complications, repeat surgeries due to recurrence or prolapse) 
occurring/performed within 12 years (Paper I)/10 years (Paper II) of primary surgery 
were included. In the survival and Cox regression analyses, recurrence of UI was 
recorded at the date of the first visit for bothersome symptoms following primary 
surgery (leading to/not leading to repeat UI surgery), or censored at the date of last 
visit with reported continence in the medical record or the date of repeat surgery due 
to complication or prolapse, when repeat surgery occurred prior to symptoms of 
incontinence. In the survival analysis of de novo OAB, the study participants became 
“cases” at the date of the first visit for bothersome symptoms, or they were censored at 
the date of the last visit without symptoms of OAB or the date of repeat surgery due to 
recurrence or prolapse if surgery took place prior to bothersome symptoms. In the 
survival analysis of prolapse surgery, study participants were recorded at the date of 
prolapse surgery, or censored at the date of the last visit without prolapse surgery or 
the date of repeat surgery due to recurrence if it was performed prior to prolapse 
surgery. 
As the department introduced a standardised 3-year follow-up from 2009 onwards, we 
chose to assess changes in outcomes in three different time periods (1998-2003, 2004-
2008, and 2009-2012) in Paper II. We also performed separate analyses of recurrence 
for the time periods 1998-2008 and 2009-2012 in Paper III. 
In order to maintain power in Paper III, we restricted analyses of recurrence to 
surgeons A, B, and C, as they had all performed >50 surgeries. To investigate whether 
the recurrence rates decreased as the surgeons gained more experience, we performed 
a hypothesis test which stated that the recurrence rate is constant and equal to the 
mean recurrence rate over all surgeries (H0) or the recurrence rate is a logit function of 
the number of surgeries performed (H1). These hypotheses give the probability (p-
value) of observing a change in recurrence rate, as the recurrence rate is unaffected by 
surgeon’s experience.  
The recurrence rate was estimated using logistic regression, assuming a binomial 
distribution. Binomial distribution describes a situation in which each observation (in 
this case each TVT procedure) has only two possible outcomes (in this case recurrence 
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or no recurrence). For each surgeon, the five first surgeries in each time period were 
pooled to avoid the effect of highly variable recurrence rates for a small number of 
surgeries. 
 
Each patient had a maximum of 12 years (Paper I)/10 years (Papers II and III) of 
follow-up; all analyses were stopped for any outcome thereafter due to few 
observations. 
 
8.6 Ethical approval 
 
The Regional Committee for Medical and Health Research Ethics (REC-North ref. 
number 2012/1238/REK nord; date of approval: 8 April 2013) and the Patient 
Ombudsman, Nordland Hospital, Bodø, have reviewed and approved the study 
protocol (Appendix 3). 
 
 
9 Main results 
 
9.1 Primary outcome - recurrence 
 
The 12-year cumulative recurrence rate of UI after primary surgery among women 
with preoperative SUI was significantly higher in the Burch group (p = 0.03) than in 
the TVT group, with no difference for women with MUI (p = 0.74) (Paper I). 
 
Within 10 years of surgery, women with MUI had a significant, higher recurrence rate 
compared to those with SUI (25.2% versus 13.8%; p = 0.001). No other risk factors 
predicted recurrence (age, overweight, parity, previous hysterectomy, comorbidities, 
or UR at primary surgery) (Paper II). 
 
Only three surgeons had enough surgeries for the assessment of performance on 
effectiveness. In 1998-2008, when surgeons were building competence, surgeons A (p 
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= 0.24) and C (p = 0.04) had a decreasing slope for recurrence, while surgeon B had a 
nearly flat slope (p = 0.71) (Paper III). 
Due to better surveillance, the overall and individual recurrence rates nearly doubled 
from 1998-2008 to 2009-2012. In the latter period, the recurrence rate among patients 
of surgeon A was 19.6% (based on procedures 99 through 190) and 30.1% for surgeon 
B (based on procedures 135 through 237, p = 0.09) (Paper III). 
In 2009-2012, recurrence occurred more often among patients with MUI in the TVT 
group (odds ratio 2.4, 95% confidence interval 1.2-4.9) compared to those who had 
SUI as indication for surgery (odds ratio 1.5, 95% confidence interval 0.7-2.9). We 
found the same differences in treatment effectiveness between surgeons in women 
with MUI and SUI (Paper III). 
The recurrence curves by increasing number of surgeries indicated that each surgeon 
had an individual performance level, and we found no evidence of any statistically 
significant effect of better performance in surgeons who had performed a large number 
of TVT procedures (Paper III). 
9.2 Secondary outcomes 
9.2.1 Perioperative complications 
We found similar overall rates of perioperative complications and no significant 
differences in the prevalence of bladder injury and bleeding/hematoma between 
women in the Burch and TVT groups (Paper I). We found stable rates of 
bleeding/hematoma, bladder perforation, and other complications by indication for 
surgery and across time periods. We explained the higher number of bladder 
perforations in 1998-2003 (n = 7) compared to 2009-2012 (n = 1) (p <0.04) by 
surgeon’s experience (Paper II). There were no significant differences in the total rates 
of perioperative complications by category of surgeon’s experience with the TVT 
procedure. However, the risk of bladder perforation decreased significantly when the 
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surgeon had performed ≥50 primary TVT procedures compared to fewer surgeries (p = 
0.03) (Paper III). 
9.2.2 Voiding dysfunction/urinary retention 
In Paper I, we found similar rates of early VD in the Burch (7.9%) and TVT (6.1%) 
groups. Only two patients had late VD in the form of permanent need of 
catheterisation, both of whom were in the TVT group. There were similar rates of UR 
among women with SUI (5.6%) and MUI (4.4%) in Paper II. In Paper III, UR was 
more often diagnosed when the surgeon had performed 19 or fewer primary TVT 
procedures compared to a higher volume of surgeries (p = 0.06). 
9.2.3 Late complications 
In Paper I, the cumulative rates of de novo OAB in the Burch and TVT groups were 
similar (p = 0.86). Nine patients had tape or suture material complications: one (0.8%) 
in the Burch group and eight (4.4%) in the TVT group (p = 0.06). Only two patients 
had late VD in form of need of catheterisation, both of whom were in the TVT group. 
In Paper II, 17 (2.9%) women had late tape complications within 10 years of primary 




10.1 Primary outcome - recurrence 
Paper I revealed a significant, higher cure rate up to 12 years after primary surgery for 
the TVT procedure compared to the Burch colposuspension in women with 
preoperative SUI. Ogah’s meta-analysis on randomised controlled trials reported no 
difference in effectiveness between the Burch colposuspension and the TVT procedure 
at 5-year follow-up (92). However, our overall 74.7% (95% confidence interval 66.5-
82.9%) subjective cumulative cure rate at 12-year follow-up in the TVT group is in 
line with other reports (94) (95) (98) (126) (127) (128). Our study included only open 
Burch colposuspension, but even in newer publications comparing MUS surgery and 
laparoscopic Burch colposuspension, the superiority of the retropubic TVT procedure 
over the Burch colposuspension seemed to be confirmed (129). 
Very few studies have assessed the long-term effectiveness of the Burch 
colposuspension and stratified data for SUI and MUI. Lose et al. found objective cure 
rates of SUI symptoms after the Burch colposuspension of 94% and 75% in women 
with SUI and MUI, respectively (130), whereas Eriksen found corresponding rates of 
71% and 57% 5 years after Burch colposuspension (131). Regardless of the procedure, 
women with MUI have a lower chance for cure than women with SUI. We did not find 
any significant difference in effectiveness between the Burch colposuspension and the 
TVT procedure in women with MUI. Several factors may contribute to the explanation 
of this result. The TVT procedure may compensate for the laxity of the anterior 
vaginal wall and the pubourethral ligaments by providing support for the mid-urethra, 
but not for more serious neuromuscular impairments that could give rise to UUI 
symptoms in these women, according to Brucker’s “common pathway” theory (51). 
Furthermore, subjective and objective cure after UI surgery are not the same, 
especially not in women with MUI, where both SUI and UUI symptoms, as well as 
other factors, contribute to the patient’s satisfaction at follow-up.  
Furthermore, MUI was the only factor that predicted recurrence within 10 years of 
primary TVT surgery. The covariates age, overweight, parity, comorbidities, and UR 
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had no impact on the effectiveness of TVT surgery. Women with MUI had a 
significantly lower satisfaction rate compared to those with SUI at the first follow-up 
visit. 
The overall cumulative subjective cure rate at 10-year follow-up (69%) was somewhat 
lower than results from comparable studies (75-80%) (97) (101). When we stratified 
our results into pure SUI and MUI, the cumulative subjective cure rate at 10-year 
follow-up was 74% for women with pure SUI (95% confidence interval 66-82%) and 
58% (95% confidence interval 48-68%) for those with pure MUI. Thus the long-term 
SUI cure rate was lower in our study than in other studies (77-90%) (93) (95), while 
the women with MUI had a higher cumulative subjective cure rate compared to other 
studies (37-55%) (94) (96).  
In line with other reports, we found that the effect of surgery showed a higher decrease 
over time in women with MUI than in those with SUI (132). As we applied survival 
analyses in our study, we expected the estimates of cure rates to be lower, as 
recurrence was estimated only among those patients that remained in the study at the 
different time intervals. This differs significantly from most other studies, in which 
time and number of patients actually completing follow-up were not taken into 
account when estimating recurrence; instead the total number of patients who had 
surgery was used as the denominator (93) (95) (102) (133). 
Only a few published studies have looked at perioperative complications as an 
independent risk factor for recurrence (101) (102). One explanation they offered for 
this association is that perioperative complications may lead to injury of the complex 
interplay between connective tissue, muscles, and innervation, all of which are 
essential for the support and functioning of the mid-urethra, which in turn ensures 
stress continence (34). However, as these complex mechanisms are already damaged, 
disturbed function of the tape itself may be a more plausible explanation. Hematoma, 
bleeding, and surgical site infection may deteriorate the optimal function of the tape. 
This is consistent with our findings that UR was not associated with a reduced cure 
rate, as we assumed that the mechanism of UR was too much tightening of the tape 
without traumatising the tissue. Intense or prolonged inflammation and immature 
collagen synthesis are also factors that have been hypothesised to disturb the optimal 
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biocompatibility and clinical performance of the mesh (134) (135). Our study showed 
a possible association between recurrence and non-UR perioperative complications. 
However, due to the low number of cases with such complications and inconsistency 
between women with SUI and MUI, this finding has to be interpreted with caution. 
In studies that reported an association between overweight, advanced age, and lower 
cure rates, the results may have been influenced by the inclusion of women with past 
UI surgery and/or past or concomitant prolapse surgery (95) (101), which is not the 
case in our study.  
In Paper III, we did not find any statistically significant association between surgeon’s 
experience and risk of recurrence in two of the three surgeons during a maximum of 
10 years of follow-up. However, for surgeon A, there was a tendency towards a 
declining rate of recurrence with increasing number of TVT procedures performed in 
the period 1998-2008. We found a statistically significant reduction in recurrence rate 
by number of TVT operations performed only for surgeon C, who was by far the most 
experienced gynaecologist in the department. During his early learning phase of about 
30 primary TVT procedures, he performed a higher proportion of the procedures not 
included in the study and participated in the training of less experienced surgeons to a 
greater extent than did surgeons A or B. In the period 2009-2012, surgeons A and B 
had already achieved a significant level of experience, and inconsistent changes in 
recurrence rates were observed with increasing number of TVT procedures. Thus, 
there may be a weak association between recurrence rate and surgeon’s experience up 
to 67 primary TVTs performed, but this result has to be interpreted with caution due to 
the inconsistency between the three surgeons. 
We found that recurrence rates by surgeon varied between 10.2% and 30.1%. 
However, this apparently wide range of variation is most likely due to both actual 
individual variations between surgeons and differences in follow-up across time 
periods. In our opinion, bias due to a different case-mix across surgeons is unlikely, as 
higher age, low parity, and previous hysterectomy are inconsistently reported, or not 
reported at all, as risk factors for recurrence (136). The recurrence curves by 
increasing number of surgeries indicate that each surgeon has an individual 
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performance level, but we have no evidence of any statistically significant effect of 
learning beyond 67 TVT procedures performed. 
We found an increase in recurrence rates after the introduction of a systematic 3-year 
follow-up among women who received surgical treatment from 2009 onwards (Papers 
II and III). Before 2009, recurrences occurring after the first follow-up were diagnosed 
after referral from general practitioners or private gynaecologists. Systematic follow-
up allowed us to also identify recurrences that were not so bothersome that the women 
sought medical advice. However, the increase in recurrence rates was significant only 
for women with MUI. There are some epidemiological differences between women 
with SUI and MUI, as those with MUI are older, more often overweight, and more 
often have comorbidities. However, after adjusting for these risk factors, the increase 
in recurrence rates from the early to the late time period remained, including in 
analyses stratified for the two doctors performing surgery in both time periods. This 
finding confirms that MUI is an important risk factor for recurrence. 
10.2 Secondary outcomes 
10.2.1 Comparison of the Burch colposuspension and the tension-free vaginal tape 
procedure 
Ogah’s meta-analysis comprised six randomised controlled trials that compared the 
Burch colposuspension and the TVT procedure and reported fewer perioperative 
complications, less early VD, shorter operative time, and shorter hospital stay. 
However, the meta-analysis identified significantly more bladder perforations in the 
TVT group than the Burch group (92). Our study did not find any significant 
difference in the number of perioperative complications, including bladder 
perforations and early VD (catheterisation >1 week). However, women with 
perioperative complications in the Burch group had a significantly longer hospital 
stay, probably due to a combination of more serious complications, a significantly 
higher rate of urinary infections (p <0.01), and a gradual change in handling of early 
VD from prolonged hospital stay with permanent catheter to instruction in self-
catheterisation before discharge from hospital. Furthermore, the traditional way of 
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handling surgical patients, with a gradual shift from inpatient to outpatient surgery, 
took place in parallel with the introduction of the TVT procedure. 
 
Due to differences in definitions, selection of patients, and completeness and length of 
follow-up, rates of late complications differ between studies. Studies on long-term 
follow-up after TVT have found rates of de novo UUI to vary between 4% and 17%, 
and rates of VD between 23% and 32% (95) (98) (106) (120) (126) (137) (138). For 
the Burch group, reported rates of de novo UUI varied between 15% and 41%, and 
rates of VD between 2% and 36% at long-term follow-up (76) (77) (78) (79). So far, 
however, there are few studies with 12-year follow-up data. In our study, the 
cumulative rates of OAB symptoms at 12 years indicate that late complications may 
develop many years after surgery. We did not find any significant difference in the 
rate of OAB between the two surgical methods. This finding fits with the knowledge 
that the prevalence of urgency, UUI, and detrusor underactivity increase with age, and 
hence contribute to some long-term problems regardless of UI surgery (1) (139). 
However, and not surprisingly, the rate of complications related to tape and suture 
material was higher in the TVT group than the Burch group. 
 
10.2.2 Safety of the tension-free vaginal tape procedure 
 
Most studies assessing UR show that the need for catheterisation resolves 
spontaneously within 1 week of surgery, leading to large variations in published rates 
of women with postoperative UR (105) (117) (140). In our study, only nine patients 
(1.5%) reported serious problems with bladder emptying more than 3 months after 
surgery. Other studies that assessed UR after TVT have reported a rate of “very 
disturbing UR” of 1.2% more than 1 year after TVT (117) (140) (141). 
 
Pain and discomfort in the pubic region have been reported in 7.5% of women after 
TVT surgery (142). This discomfort may resolve after some time (143). Sexual 
dysfunction following the TVT procedure is common. Both dyspareunia and leakage 
during intercourse have an impact on sexual function. According to Tunuguntla et al., 
a significant number of women report dyspareunia after sling surgery for UI, whereas 
some patients report improvement in overall sexual function due to relief of leakage 
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during intercourse (144). This is in line with Serati et al., who reported that 10-27% of 
women with UI report coital UI. They claim that coital UI during penetration is 
associated with SUI and has an 80% chance of being cured by surgery (145). 
Furthermore, Lindquist and Glavind reported an improvement in sexual function at 
follow-up nearly 5 years after TVT (143).  
 
Only a small proportion of our TVT group reported a negative impact of the tape on 
sexual function. However, neither the rate of intercourse-related tape symptoms nor 
the relief of leakage during intercourse was systematically examined in our follow-up 
study, and thus may be underreported.  
 
In our study, 2.9% of patients experienced long-term tape-related problems. Of these, 
less than 50% required repeat UI surgery. Only two patients needed major surgery: 
one due to fistula, and one with resection of the tape due to pain. This is in accordance 
with most other long-term studies that showed an incidence of tape complications 
ranging from 0% to 4.2% (98) (105) (106) (107) (108). The largest study to-date on 
late tape-related complications is the retrospective cohort study by Keltie et al. (146), 
which assessed 41,880 primary TVT surgeries in England between 2007 and 2015. In 
that study, the rate of surgery due to late tape complications was 2.7% in form of 
removal and 1.0% in the form of repair. However, data on removals was not stratified 
by major and minor surgeries, as removal may comprise both total removal and partial 
resection of the mesh. In our study, the number of major surgeries comprised only a 
small proportion of the surgeries needed due to complications. 
 
10.2.3 Surgeon’s experience and safety of the tension-free vaginal tape procedure 
 
Several mechanisms can provide an explanation for complications that may arise in 
operations performed by less experienced surgeons. Inappropriate placement of the 
tape in the vaginal wall, too superficial or too deep, may increase the risk of erosion of 
the vaginal mucosa and perforation of the urethra, respectively. As the tape should 
provide support to the mid-urethra, placement of the tape too far distally or too far 
proximally may have an impact on treatment effectiveness. Inappropriate direction of 
the introducer device during placement of the tape into the retropubic space may 
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increase the risk of bladder perforation, and inappropriate tightening of the tape may 
increase the risk of either UR or reduced treatment effectiveness. 
We did not find any statistically significant differences in the overall rate of 
perioperative complications by surgeon’s experience. However, surgeons who had 
performed <50 TVT procedures had a significantly higher risk of bladder perforation 
compared to surgeons who had performed >50 procedures. However, we found a 
higher risk of bladder perforation in the middle category of surgeon’s experience with 
TVT procedures (20-49; 5.8%) compared to the lowest category (‘beginner’, 1-19; 
2.7%). This is probably an effect of the assistance from an experienced surgeon giving 
supervision in the ‘beginner’ phase. In Hilton’s study (111), which assessed the 
learning phases of 16 surgeons who performed 1568 TVT procedures in total, the 
number of TVT procedures necessary to achieve a rate of bladder perforation ≤5% 
varied between 20 and 80. It is assumed that there is hardly any harmful effect of a 
bladder perforation, as these injuries are detected at the cystoscopy, which is always 
performed followed by withdrawal and re-introduction of the device on the same side 
as the perforation. 
While Duckett et al. found no difference in UR rate between groups of surgeons with 
different levels of experience (117), Lebret et al. reported a significant, increased risk 
of UR during the first 50 TVT procedures compared to the subsequent 50 (114). We 
found a borderline significant increased risk of UR during the first 19 TVT procedures 
compared to the procedures thereafter, which may indicate that the learning phase 
comprises the first 20-50 TVTs for this particular outcome. These results emphasize 
both individual variations in the length of the learning phase (111), as well as 
disparities among surgeons across outcomes.  
Three studies have reported evidence of an association between higher level of 
experience and lower risk of perioperative complications (109) (110) (119). However, 
we did not find any difference in the overall rate of perioperative complications by 
surgeon’s experience (p = 0.36). 
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10.3 Strengths and limitations 
 
When planning this study in 2012 and beyond, the only feasible study design was a 
retrospective case-series approach. As the Burch colposuspension is hardly performed 
anymore, a case-series design is the only viable method for comparison. We were able 
to conduct a comparison between the Burch colposuspension and the TVT procedure 
in an overlapping time period. 
 
The strength of our study is the fact that all surgeries were performed in one 
department by its regular doctors. Thus we had consistent practices in the selection of 
patients, performance of surgery, and follow-up. 
 
In order to avoid any confounding effect of earlier and concomitant pelvic floor 
surgery on effectiveness, we included only patients who underwent primary UI 
surgery without previous or concomitant prolapse surgery. In our analyses of 
recurrence, patients were censored at the date of surgery due to both prolapse and 
complications in order to avoid interpretation problems for outcomes occurring after 
these interventions. 
 
Very few studies that have reported on effectiveness as a function of surgeon’s 
experience have a sufficiently long follow-up time or a large enough sample size to 
find an effect (102) (105) (113) (118). Conversely, we had a large sample size, the 
proportion of patients with follow-up data was high, and the follow-up time was long 
enough for a valid comparison. 
 
The most important weakness of this study is its retrospective design. Data were not 
collected systematically as in prospective studies. A prospective trial would have a 
protocol with a schedule for follow-up and systematic registration of data. In this 
retrospective study, our data relied upon stringent documentation in medical records. 
Grading of symptoms and complaints were based on the patient’s subjective 
description, and how the doctor perceived these complaints and recorded them in the 
medical record. It is my impression that the quality of this type of documentation has 
improved over the years. Regarding data dependent on more complex clinical 
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judgement, for example classifying UI as either SUI or MUI, or diagnosing 
recurrence, the assessments of the doctors who offered women surgical treatment, the 
surgeon who performed the procedure, and the doctor who performed the follow-up 
were weighted most heavily. However, when I transferred these data to the case report 
form made for this particular study, I had to make the final decision based on the 
information in the medical record. When we planned this study in 2012-2013, we 
found it too time-consuming to involve two reviewers in the transfer for data from 
medical records to case report forms. We could have created a panel of two to three 
urogynaecologists to assist in cases where I found it difficult to settle on any outcome, 
for example recurrence or erosion, but we did not include such a back-up when we 
wrote the protocol. 
 
We have systematic follow-up data from outpatient clinics 6-12 months after surgery 
for a high proportion of patients. From 2002 onwards, the documentation of symptoms 
was more systematic, as we applied a validated questionnaire introduced by the 
Norwegian Incontinence Registry both at preoperative counselling and at 6-12 month 
follow-up. For patients who underwent surgery from 2009 onwards, we introduced a 
systematic 3-year follow-up with a validated questionnaire. However, much of the 
data in our study are from referrals made by general practitioners and private 
gynaecologists of women who sought medical advice due to bothersome symptoms. 
 
Thus, we have to take into account reporting bias across time periods due to changes 
in quality, methods, and frequency of follow-up. There is likely a relative 
underreporting of recurrence in the early compared to the late time periods. As we 
found a higher recurrence rate in the Burch group, who had their operation in the 
earliest time period (1994-1999), this bias will not change our main conclusions in 
Paper I. For the same reason, we performed separate analyses of recurrence for three 
and two time periods, respectively, in Papers II and III. 
 
There are some other possible causes of reporting bias across time periods. A larger 
proportion of women were below 50 years of age in the period 2009-2012 (47.8%) 
compared to 1998-2008 (40.2%), and a younger population may have higher 
expectations of cure after surgery and a lower threshold for seeking medical advice. 
There was also an increase in the proportion of women who resided in our hospital’s 
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local catchment area, from 69.2% in 1998-2008 to 85.7% in 2009-2012. A higher 
proportion of patients living the catchment area and a more standardised follow-up 
procedure in the last period may give more valid results which reflect a “true” quality 
of care regarding all outcomes in this period compared to the years before 2009.  
There is a possible loss to follow-up among women who had repeat surgery at 
hospitals in other parts of Norway, as new legislation passed in 2001 gave people the 
right to choose their healthcare provider. However, a previous report stated that 
Norwegian patients have high loyalty to their local hospitals, especially in the rural 
areas in northern and western Norway. Thus the number of patients lost to hospitals 
outside of our catchment is likely very low (147). 
11 Conclusions and implications 
The aims of this study were to explore the shift from the Burch colposuspension to the 
retropubic TVT procedure with respect to long-term clinical outcomes. Furthermore, 
we wanted to explore the safety and effectiveness of the procedures, and try to identify 
any risk factors for recurrence after the TVT procedure. The last paper was an 
assessment of surgeon’s experience and clinical outcomes. The same study population 
was applied for all three papers. 
At follow-up 12 years after primary surgery, the effectiveness of the retropubic TVT 
procedure was superior to that of the Burch colposuspension in women with SUI. 
There were no significant differences in the rates of perioperative and late 
complications, but the Burch group had a 3-fold risk of later prolapse surgery 12 years 
after UI surgery, both for women with SUI and MUI.  
Compared to the Burch colposuspension, the TVT procedure represented a significant 
improvement in the surgical treatment of women with pure SUI. We did not find any 
difference in recurrence rates or complications between women with MUI in the Burch 
and TVT groups. Despite no significant improvement in effectiveness for women with 
MUI, the TVT procedure is still a better option for this group, as this method is 
minimally invasive, and has a lower rate of later prolapse surgery and repeat UI 
52 
surgery compared to the Burch colposuspension. However, tape-related problems 
apply only to the TVT procedure. 
Women with MUI comprised one-third of our study sample and were more often 
dissatisfied after surgery than women with SUI. At preoperative counselling it is 
important to give realistic information to this group about outcomes after the TVT 
procedure. 
In some countries, reports of possible harmful effects of vaginal implants has caused 
public concern about the safety of the TVT procedure (103). However, in our study the 
rate of major repeat surgery due to late complications after primary TVT operation 
was very low (0.3%).  
Our data suggest that there is a learning phase for TVT surgeons, and that experience 
is associated with bladder injury and UR, and to a lesser extent with effectiveness. 
Furthermore, we found individual variations in outcomes between surgeons, and the 
length of the learning phase may vary across surgeons on type of outcome. These 
factors have to be taken into account at teaching hospitals when educating residents 
and young surgeons in new techniques. Thus, in order to avoid complications and 
recurrences, it is important that surgical skills be carefully evaluated before 
‘beginners’ are allowed to perform TVT procedures on their own. 
Monitoring of long-term outcomes is time-consuming, but highly necessary, as it 
represents important feedback for surgeons, the hospital, and society. This emphasizes 
the importance of high-quality national registries like The Norwegian Female 
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Abstract
Introduction and hypothesis The retropubic tension-free
vaginal tape (TVT) procedure replaced Burch
colposuspension as the primary surgical method for
stress urinary incontinence (SUI) and mixed urinary in-
continence (MUI) in women in our department in 1998.
In this study we compared the short-term and long-term
clinical outcomes of these surgical procedures.
Methods Using a case series design, we compared the last
5 years of the Burch procedure (n = 127, 1994–1999) with
the first 5 years of the retropubic TVT procedure (n = 180,
1998–2002). Information from the medical records was trans-
ferred to a case report form comprising data on perioperative
and long-term complications as well as recurrence of UI,
defined as bothersome UI or UI in need of repeat surgery.
Other endpoints were rates of perioperative and late compli-
cations and the rates of prolapse surgery after primary surgery.
The data were analyzed with the chi-squared and t tests and
survival analysis using SPSS.
Results The cumulative recurrence rate of SUI in women
with preoperative SUI was significantly higher after the
Burch procedure, but no difference was observed in
women with MUI. There were no significant differences
in rates of perioperative and late complications. At
12 years there was a significant increase in rates of
repeat surgery for incontinence and prolapse in women
after the Burch procedure.
Conclusions The long-term efficacy of TVT surgery was su-
perior to that of Burch colposuspension in women with SUI.
In addition, the rate of late prolapse surgery was significantly
higher after the Burch procedure.
Keywords Burch colposuspension . Complications .
Long-term results .Midurethral slings .Mixed urinary
incontinence . Stress urinary incontinence
Introduction
Until the late 1990s Burch colposuspension was considered
the gold standard in the surgical treatment of stress urinary
incontinence (SUI) and mixed urinary incontinence (MUI)
in women [1]. The surgery is an open procedure requiring
general or regional anesthesia, and involves a hospital stay
of 7–10 days followed by sick leave of 3–4 weeks. In 1995
Ulmsten et al. described the retropubic tension-free vaginal
tape (TVT) as a new surgical treatment for female urinary
incontinence (UI) [2]. The TVT operation is an outpatient
procedure performed under local anesthesia, requiring sick
The abstract of this work was presented as a poster presentation at the
40th Nordic Congress of Obstetrics and Gynecology, Helsinki, 12–15
June 2016, and at the Annual Assembly of the Norwegian Association
of Gynecology and Obstetrics, Lillestrøm, 26–28 October 2016.
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leave of 10–14 days. The first reported case series showed
high safety and efficacy at 2 years [3–5]. Within a few years,
the TVT procedure replaced Burch colposuspension as the
preferred surgical method worldwide.
Five case series of Burch procedures with more than
5 years follow-up and two with more than 10 years
follow-up have shown subjective cure rates between
44% and 80%, and objective cure rates between 67%
and 82%. However, efficacy appears to decrease with
time [6–10]. Until 2005, neither randomized controlled
trials (RCTs) nor meta-analyses had revealed any signif-
icant differences in efficacy at 5 years in favor of the
TVT procedure [11, 12]. The first study showing high
efficacy of the TVT procedure with a long-term per-
spective (>10 years) was published in 2008 [13], and
later several studies have shown similar results [14–18].
The safety of suburethral sling surgery has been
questioned in recent years. An editorial from the
Cochrane Library in June 2015 summarized 20 years
of experience of surgical treatment of UI in women.
The authors questioned the fact that only a few of the
35 trials including long-term follow-up showed leakage
and adverse effects at 5 years or later. The editorial also
referred to a report from the UK Medicines and
Healthcare Products Regulatory Agency (MHRA) that
concluded: BWomen have reported serious and debilitat-
ing problems following surgical treatment for SUI vag-
inal tape implants.^ The authors thus questioned the
safety of vaginal tape implants and requested more ev-
idence about safety with new methods in comparison
with older abandoned methods [19].
The aim of this study was to compare short-term and
long-term clinical outcomes in women undergoing Burch
colposuspension and the retropubic TVT procedure.
Materials and methods
The Department of Gynecology at Nordland Hospital,
Bodø, Norway, introduced the TVT procedure in 1998.
Within a year, TVT had replaced Burch colposuspension
as the preferred method. We identified all patients under-
going UI surgery during the period 1994–2012. A total of
896 procedures had been performed. Patients who had
undergone earlier or concomitant prolapse surgery
(n = 35), earlier UI surgery (n = 52) and surgical proce-
dures for UI other than open Burch colposuspension or
re t ropubic TVT surgery (n = 58, including 45
laparoscopically performed Burch operations) were ex-
cluded from the study. For the present analysis the study
population was restricted to the last 5 years of Burch
colposuspension (n = 127, 1994–1999) and the first
5 years of TVT surgery (n = 180, 1998–2002). Thus the
study included a total of 307 women who had undergone
primary UI surgery.
Electronic medical records were screened in retro-
spect and the information was transferred to a case re-
port form especially designed for the study. For patients
referred from neighboring hospitals (n = 147), the med-
ical records at all hospitals in Nordland County were
examined. The following preoperative data were includ-
ed: type of UI (SUI/MUI), age (≤49, 50–59, ≥60 years),
parity (0, 1, 2, 3+), menopausal status, body mass index
(BMI), earlier hysterectomy and relevant comorbidities.
From the preoperative examination prior to primary and
repeat surgery, the following information was collected:
previous conservative treatment for UI including pelvic
floor muscle training (PFMT) and electrostimulation,
and urodynamic examinations such as cystometry and
uroflowmetry assessments with description of the form
of the curve and an estimate of maximum flow rate
(less than or more than15 ml/s). In addition, the results
of a standardized stress test (coughing during gyneco-
logical examination with 300 ml saline in the bladder)
and measurement of residual urine were included [20].
The type of incontinence was classified on the basis
of a combination of data on symptoms as documented
in the medical record, and outcomes of stress tests and/
or urodynamic examinations. Also recorded were the
date and type of surgery, type of perioperative compli-
cations, date and type of surgery for perioperative com-
plications, date of the first visit for symptoms of com-
plications and type of late complications, date of the
first visit for symptoms of recurrence and date and type
of surgery for possible late complications, date and type
of repeat UI surgery, date and type of urinary symptoms
at the last visit (including no symptoms), and date of
possible prolapse surgery following UI surgery.
Perioperative complications included bladder injury
(defined as perforation of trocar, tape or sutures), early
voiding dysfunction (VD, defined as the need for cath-
eterization for 1 week or more), bleeding/hematoma
(bleeding defined as surgeon’s description of significant
bleeding intraoperatively, and hematoma as clinically or
ultrasonographically identified hematoma of any size),
urinary infections and other complications. Recurrence
of UI was defined as the presence of any bothersome
symptoms of SUI documented in the medical record
and/or identified by standardized stress tests and
urodynamic examinations on follow-up. Late complica-
tions were divided into symptoms of overactive bladder
(OAB), late VD, tape complications, and others. OAB
was defined as de novo urgency or, in women with
preoperative SUI, as de novo urgency UI. Late VD
was defined as the permanent need for catheterization.
Tape complications were defined as erosion with
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symptoms or erosion without symptoms diagnosed acci-
dentally, fistulas, chronic pain/discomfort or dyspareunia
without any other obvious explanation. Information
about recurrent urinary infection without any other com-
plaints was not considered a late complication.
Statistical analysis
The data were analyzed with the chi-squared and t tests
and survival analysis. In all the analyses only recur-
rences, late complications, repeat incontinence surgery
and prolapse surgery occurring/performed within
12 years of primary surgery were included. In the sur-
vival analysis, the recurrence of UI was recorded at the
date of the first visit for bothersome symptoms follow-
ing primary surgery (leading to/not leading to repeat
surgery), or censored at the date of the last visit at
which continence was documented in the medical re-
cord, or at the date of prolapse surgery, when prolapse
surgery was performed prior to the occurrence of incon-
tinence symptoms. In the survival analysis of de novo
OAB, the study participants became Bcases^ at the date
of the first visit for bothersome symptoms, or were cen-
sored at the date of the last visit at which they were
free of symptoms of OAB, or at the date of repeat
incontinence surgery/prolapse surgery, if surgery took
place prior to the occurrence of bothersome symptoms.
In the survival analysis of prolapse surgery, the study
participants were recorded at the date of prolapse sur-
gery, or censored at the date of the last visit without
prolapse surgery, or at the date of repeat incontinence
surgery, if repeat incontinence surgery was performed
prior to prolapse surgery.
The Ethics Committee for Medical and Health
Research, North Norway, Tromsø, and the Patient
Ombudsman, Nordland Hospital, Bodø, reviewed the
study protocol.
Results
There were no differences in baseline characteristics between
the Burch group and the TVT group (Table 1). The mean ages
of the women in the Burch group and the TVT group were
54.5 years (SD 11.5) and 55.2 years (SD 12.1; p = 0.63),
respectively, and their mean parities were 3.0 (SD 1.2) and
2.6 (SD 1.2; p < 0.01), respectively. With regard to preopera-
tive conservative treatment, 66.9% of the women (85/127) in
the Burch group and 68.3% (123/180) of those in the TVT
group (p = 0.80) had performed PFMT, electrostimulation or
Table 1 Characteristics of the
study population according to the
surgical procedure performed







25–49 44 (34.6) 65 (36.1) 0.10
50–59 51 (40.2) 53 (29.4)
60–93 32 (25.2) 62 (34.4)
Body mass index (kg/m2)
Missing 7 (5.5) 7 (3.9) 0.36
17.21–24.99 45 (35.4) 57 (31.7)
25.0–29.99 60 (47.2) 84 (46.7)
30.00–37.80 15 (11.8) 32 (17.8)
Parity
0/1 10 (7.9) 26 (14.4) 0.12
2 38 (29.9) 60 (33.3)
3+ 79 (62.2) 94 (52.2)
Menopausal status
Premenopausal 52 (40.9) 64 (35.6) 0.49
Perimenopausal 13 (10.2) 25 (13.9)
Postmenopausal 62 (48.8) 91 (50.6)
Hysterectomy (yes) 12 (9.4) 20 (11.1) 0.64
Comorbidity
Cardiovascular (yes) 28 (22.0) 35 (19.4) 0.58
Pulmonary (yes) 9 (7.1) 22 (12.2) 0.14
Neurological (yes) 11 (8.7) 21 (11.7) 0.40
Type of incontinence
Mixed 32 (25.2) 55 (30.6) 0.31
Stress 95 (74.8) 125 (69.4)
a Pearson chi-squared test
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both prior to primary surgery. The medical records showed a
positive standardized stress test in 78.0% (99/127) of women
in the Burch group and in 94.4% (170/180) of women in the
TVT group (p < 0.001). Urodynamic examinations including
uroflowmetry and/or cystometry, in addition to clinical evalu-
ation with stress tests and measurement of residual volumes,
were performed in 120 women in the Burch group (94.5%)
and in 178 women in the TVT group (98.9%; p = 0.002).
There were no significant differences in total rates of
early complications (Table 2). The frequencies of early
VD, bladder injury and bleeding/hematoma were similar,
as well as the rates of reoperation due to early complica-
tions in the Burch group and the TVT group (3.1% and
2.2%, respectively; p = 0.62). Among the patients with
bladder injury, two had the tape removed intraoperatively
and later underwent repeat TVT surgery, and thus were
included in the analysis of repeat incontinence surgery.
Of patients with early VD, 11 reported a permanent prob-
lem with bladder emptying of any degree, 3.1% (4/127) in
the Burch group and 3.9% (7/180) in the TVT group
(p = 0.73), and of these seven patients in the TVT group,
two needed permanent catheterization.
All surgical procedures were performed on an inpatient
basis. The mean postoperative hospital stay was 6.3 days in
the Burch group (range 3–22 days), and 2.2 days in the TVT
group (range 0–15 days; p < 0.01). The postoperative hospital
stay was protracted (>7 days) in 19.7% of patients in the
Burch group and in 4.4% of patients in the TVT group
(p < 0.01). No further follow-up was performed after the first
visit in 20 patients (15.8%) in the Burch group and in 22
patients (12.2%) in the TVT group (p < 0.40). The mean
follow-up time (within 12 years) in the Burch group
(n = 127) was 85 months (range 1–144 months) and in the
TVT-group (n = 180) was 84 months (range 1–144 months;
p = 0.86). Within 12 years, 39 women in the Burch group and
32 women in the TVT group were diagnosed with recurrent
UI. Table 3 shows the number of cumulative events. The
overall cumulative recurrence rate of UI up to 12 years after
primary surgery among women with preoperative SUI was
significantly higher in the Burch group (Fig. 1; p = 0.03,
Gehan test for survival), with no difference among women
operated on for MUI (p = 0.74, Gehan test for survival).
Overall rates of repeat UI surgery (among women with
recurrence within 12 years) were significantly different be-
tween the groups with 11.0% in the Burch group (14/127)
and 1.7% in the TVT group (3/180; p < 0.001). Among wom-
en with recurrence, 33% (14/39) in the Burch group and 9%
(3/32; p = 0.02) in the TVT group had repeat surgery. The time
from recurrence to repeat surgery varied from 1 to 136months,
with more than half of the procedures performed within
6 months of recurrence (9/17). After TVT surgery was
established as the preferred method, 11 of 12 repeat proce-
dures were TVT procedures.
The cumulative numbers of women diagnosedwith OAB up
to 12 years after primary surgery are also shown in Table 3.
There was no difference in cumulative rates of de novo OAB
between the Burch and TVT groups (p = 0.86, Gehan test for
survival). Only two patients had late VD in the form of the need
for catheterization, both in the TVT group. Nine patients had
tape or suture material complications, one (0.8%) in the Burch
group and eight (4.4%) in the TVT group (p = 0.06). In total, 11
patients required surgery due to late complications, two (1.6%)
in the Burch group due to a postoperative hernia, and nine
(5.0%) in the TVT group (p = 0.11). Of these nine women in
the TVT group requiring surgery, five had tape erosion and four
had VD where cutting of the tape was necessary.
The cumulative numbers of patients undergoing prolapse
surgery up to 12 years after primary surgery are also shown in
Table 3. The cumulative rates of patients undergoing prolapse
surgery up to 12 years after primary surgery were significantly
higher in the Burch group (p < 0.01, Gehan test for survival;
Fig. 2). However, there were no differences between the indi-
cations for primary surgery and subsequent prolapse surgery
in either group. By 12 years after primary surgery, prolapse
Table 2 Immediate perioperative
and postoperative major
complications according to the
surgical procedure performed





Voiding dysfunction 10 (7.9) 11 (6.1) 0.55
Bladder perf./injury 4 (3.1) 5 (2.8) 0.85
Bleeding/hematoma 3 (2.4) 2 (1.1) 0.39
Otherb 4 (3.1) 1 (0.6) 0.08
Totalc 20 (15.7) 19 (10.6) 0.18
a Pearson chi-squared test
b Uncomplicated urinary infection without any other complications not included. There were 23 urinary
infections in the Burch group and one in the TVT group
cNumber of patients with one or more perioperative complications
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surgery had been performed in 16.5% of patients in the Burch
group (21/127) and in 5.6% of patients in the TVT group (10/
180; p = 0.01).
Discussion
This study showed a significantly lower cumulative rate of
recurrence up to 12 years after primary surgery in women with
preoperative SUI after the TVT procedure than after Burch
colposuspension. High cure rates for the retropubic TVT
procedure persisting over time have been shown in several
studies [13–18]. However, a meta-analysis of RCTs showed
no difference in efficacy between Burch colposuspension and
TVT surgery at 5 years [12]. Our overall 74.7% (95% CI
66.5–82.9) subjective cumulative cure rate at 12 years in the
TVT group is similar to previously reported rates [13–18].
There was a significant difference in the rates of repeat sur-
gery, with a lower rate in the TVT group, a difference higher
than expected according to the difference in cumulative recur-
rence rates at 12 years. Our study showed a very low rate of
Table 3 Numbers of recurrent urinary incontinence events, women with overactive bladder and women undergoing prolapse surgery, The numbers
shown are cumulative numbers up to 12 years after the primary surgical procedure. The numbers of censored women andwomenwithout outcomes listed
at 12 years are also shown













≤1 year 7 14 4 5 18 6
≤3 years 15 16 5 7 21 6
≤6 years 25 19 9 10 25 7
≤9 years 32 29 11 16 29 11
≤12 years 39 32 16 20 38 13
Censored 45 107 45 31 13 20
No outcome
listed
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Fig. 1 Cumulative recurrence rates in women with preoperative stress
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repeat surgery after TVT, in line with the findings of other
studies [14, 18].
Our diagnosis of recurrence was mainly based on descrip-
tion of typical symptoms by the patient. More thorough inves-
tigation with stress testing and urodynamics was reserved for
patients with more serious symptoms in whom repeat surgery
was an option. Thus, efficacy in this study largely reflects the
subjective cure rate. Efficacy after UI surgery found in several
studies has been lower in women withMUI than in those with
SUI, due to persistent urgency UI and because the therapeutic
effect is mainly related to the stress component. This may
explain why we did not find any difference in efficacy be-
tween the methods of surgery among women with MUI.
One meta-analysis comparing Burch colposuspension and
TVT surgery which included six RCTs showed lower rates of
perioperative complications and early VD, and shorter opera-
tive times and hospital stay, but a significantly higher rate of
bladder perforations after TVT surgery than after the Burch
procedure [12]. Our study showed no difference in the rates of
perioperative complications including bladder perforations
and early VD (catheterization >1 week). However, patients
undergoing the Burch procedure with perioperative complica-
tions had a significantly longer hospital stay, probably due to a
combination of more serious complications, a significantly
higher rate of urinary infection (p < 0.01) and a gradual
change in handling of early VD from prolonged hospital stay
with a permanent catheter to instruction in self-catheterization
before discharge from hospital. Along with the introduction of
TVT surgery, antibiotic prophylaxis was introduced in our
department. As TVT surgery was found from the beginning
to be associated with a shorter hospital stay, many urinary
infections would have been diagnosed after discharge, and
thus would have been under-reported among women under-
going TVT surgery. In view of this, we decided not to include
urinary infection as a perioperative complication.
Rates of late complications differ among studies due to
differences in definitions, selection of patients, completeness
and length of follow-up. Studies involving long-term follow-
up after TVTsurgery have shown rates of de novo urgency UI
ranging from 4% to 17% and rates of VD from 23% to 32%
[14–16, 21–23], and after the Burch procedure have shown
rates of de novo urgency UI ranging from 15% to 41% and
rates of VD from 2% to 36% [6–9]. There are few studies with
12-year follow-up data. The cumulative rates of OAB symp-
toms in our study at 12 years indicate that late complications
can develop many years after surgery, but we did not find any
significant difference between the two surgical methods. In
this respect, we have to take into account that rates of urgency,
urgency UI and detrusor underactivity increase with age, and
this may have contributed to some of the long-term problems
reported regardless of UI surgery [24, 25].
Pain and discomfort in the pubic region have been reported
by 7.5% of women after TVT surgery [26]. Sexual
dysfunction after TVT surgery is well known. In a review of
female sexual dysfunction after vaginal surgery, Tunuguntla
and Gousse [27] found that a significant number of women
reported dyspareunia after sling surgery for UI [27]. Some
patients report improvement in overall sexual function due
to relief of leakage during intercourse. This is in line with
the findings of Serati et al. [28], who found that 10–27% of
women with UI report coital UI, and coital UI during penetra-
tion is associated with SUI and has an 80% chance of being
cured by surgery [28]. In our study eight patients (4.4%) in the
TVT group had problems associated with the tape including
discomfort, dyspareunia and symptoms from erosion. The
tape appears to have had an impact on sexual function in only
a small proportion of the TVT group, but, as tape symptoms
were not systematically examined, they may have been under-
reported in this study.
It is generally considered that there is a high risk
of the need for prolapse surgery late after Burch
colposuspension. The risk varies between 1% and 37%
in the different studies [6–9, 29]. This applies primarily
to rectocele and enterocele. A concomitant cystocele, on
the other hand, has been reported to have an approximate-
ly 80% chance of being cured by Burch colposuspension
alone [29]. The prolapse of the posterior vaginal wall is
probably due to traction on the endopelvic fascia from the
sutures in the Burch procedure. The TVT operation, on
the other hand, is a tension-free procedure that ensures
more precise support limited to the mid-urethra [2]. We
found a significant difference in the rates of prolapse sur-
gery, with a lower rate in the TVT group. In the TVT
group, a patient with a cystocele needing surgery would
often be offered surgery for the cystocele before TVT
surgery in a two-step procedure. Borstad et al. found that
27% of women with concomitant prolapse and SUI were
cured of their UI by prolapse surgery alone [30]. In our
study, the process of selection was in principle the same
in the Burch group as in the TVT group where we exclud-
ed patients with a concomitant cystocele and previous UI
surgery. There were no differences in age, parity, BMI,
previous hysterectomy and indications for surgery be-
tween the groups. Our results thus give support to the
hypothesis that the high rate of prolapse surgery seen after
Burch colposuspension may be a result of changes in the
mechanical properties of the female pelvis that do not
occur after TVT surgery. This explanation is strengthened
by the finding that in both groups of patients the rate of
prolapse surgery was not dependent on the indications for
surgery.
The strengths and weaknesses of this study should be con-
sidered. In this retrospective study, data were not collected
systematically as in prospective studies, and the recorded data
were those documented in the medical records. Grading of
symptoms and complaints was based on the patients’
Int Urogynecol J
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subjective descriptions and the data need to be interpreted
with caution as they may vary in quality and consistency.
The Burch operations were all performed by an experi-
enced senior consultant, a less experienced senior consultant
or a junior doctor under the supervision of an experienced
senior consultant. As the Burch procedure is now seldom per-
formed, there is no valid method for comparison other than by
a case-series design. We were, however, able to conduct a
comparison between these two techniques in an overlapping
time period. The strengths of the study are the fact that all
surgical procedures were performed in one department with
the same surgeons with consistent practice regarding the se-
lection of patients and performance of surgery. Furthermore,
we included only primary operations without concomitant
prolapse operations. The high proportion of patients with
follow-up data and the long follow-up time ensured the valid-
ity of the comparison.
Conclusions
The efficacy of retropubic TVTsurgery 12 years after primary
surgery appears to be superior to that of Burch
colposuspension in women with SUI. There were no signifi-
cant differences in the rates of perioperative and late compli-
cations. The Burch group had a threefold risk of later prolapse
surgery 12 years after incontinence surgery. The proportion of
patients in the TVT group with problems due to tape was low,
but we cannot rule out the possibility that these problems were
under-reported. Our study provides detailed information about
efficacy and late onset complications after TVT surgery, and
this may be important information to discuss with women
during preoperative counseling.
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Abstract
Introduction: The retropubic tension‐free vaginal tape has been the preferred 
method for primary surgical treatment of stress urinary incontinence and stress‐
dominated mixed urinary incontinence in women for more than 20 years. This study 
presents long‐term safety and efficacy data and assesses risk factors for long‐term 
recurrence.
Material and methods: In a case‐series design we assessed a historical cohort of pri‐
mary surgeries performed with the tension‐free vaginal tape procedure in 596 
women from 1998 to 2012 with follow up through 2015. Information from the medi‐
cal records was transferred to a case report form comprising data on early and late 
complications and recurrence of urinary incontinence defined as bothersome stress 
urinary incontinence symptoms. All analyses were performed with SPSS using 
Pearson chi‐square, survival and Cox regression analyses.
Results: After a 10‐year follow up, mixed urinary incontinent women (hazard ratio 
2.1, 95% confidence interval [CI] 1.4‐3.0) had a significantly increased risk of recur‐
rence of stress urinary incontinence symptoms compared with women with pure 
stress urinary incontinence as the indication for surgery. Overall cumulative cure 
rates after 1, 5 and 10 years were 92% (95% CI; 90%‐94%), 79% (95% CI; 75%‐83%) 
and 69% (95% CI; 63%‐75%), respectively. Recurrent surgery (0.3%) and serious tape 
complications needing major surgical treatment (0.3%) were rare. Six patients (1.0%) 
had the tape cut due to urinary retention, and nine patients (1.5%) reported urinary 
retention more than 3 months after surgery.
Conclusions: The tension‐free vaginal tape procedure has a high long‐term durability. 
Mixed urinary incontinence as an indication for surgery predicted long‐term recur‐
rence. Long‐term complications were rare.
K E Y W O R D S
complications, long‐term results, midurethral slings, mixed urinary incontinence, stress 
urinary incontinence, tension‐free vaginal tape
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1  | INTRODUC TION
Within a few years after the introduction of the retropubic ten‐
sion‐free vaginal tape (TVT) in 1996, several studies demonstrated 
excellent short‐term clinical outcomes, making this minimally inva‐
sive method the gold standard in the surgical treatment of women 
with stress (SUI) and stress‐dominated mixed (MUI) urinary inconti‐
nence.1,2 From 2005 and onwards, the number of women undergoing 
midurethral sling surgery increased rapidly.3 Probable explanations 
are an increased awareness of urinary incontinence (UI), a lower 
symptom threshold for surgery, as the surgical method being consid‐
ered less invasive, and a possible increase in the prevalence of UI.4
To date, several studies assessing clinical outcomes and risk fac‐
tors for failure have demonstrated excellent long‐term clinical out‐
comes after midurethral sling surgery. However, patient selection 
varies according to indication for surgery, the inclusion of women 
with repeat UI surgery, and women with previous and/or concom‐
itant prolapse surgery.5‐10 Most long‐term follow‐up studies do not 
have sample sizes large enough for risk factor analysis.5‐7 The high‐
est long‐term subjective cure rates of 77%‐90% apply only to pri‐
mary surgery on SUI women only,5,11 whereas subjective cure rates 
of 75%‐80% are reported for heterogeneous populations of women 
with both SUI and MUI.6,12 Long‐term studies including women with 
previous/concomitant pelvic surgery have reported lower subjective 
cure rates (65%‐76%).7,8 Subjective cure rates as low as 37%‐55% 
have been reported for MUI women only.13,14 Therefore, study pop‐
ulation characteristics are crucial when comparing studies and may 
explain why clinical outcomes and risk factor patterns for recurrence 
vary.
Mixed urinary incontinence as an independent risk factor for re‐
currence is well established,13‐15 but across studies, age, body mass 
index and diabetes are inconsistently reported.6,9,13,15 The possible 
impact of perioperative complications on long‐term efficacy has 
only been evaluated in a few studies.9,15
The aims of this study were to investigate clinical long‐term out‐
comes and to assess demographic, clinical and perioperative risk 
factors for recurrence within 10 years after primary retropubic TVT 
surgery.
2  | MATERIAL AND METHODS
The Department of Gynecology at Nordland Hospital, Bodø, 
Norway, introduced the retropubic TVT procedure in 1998. Within a 
year, TVT had replaced the Burch colposuspension as the preferred 
method. We identified all patients having undergone a possible UI‐
related surgical procedure during 1994‐2012 either as primary or 
recurrent surgery, in a total of 895 women (Figure 1). After exclusion 
of women having had Burch procedures solely on a prolapse indi‐
cation, past pelvic surgery, concomitant prolapse surgery, primary 
incontinence surgery other than TVT, and women with no follow up, 
the final study population comprised 596 women having had TVT as 
primary surgery for SUI or MUI. The TVT surgery was performed as 
originally described by Ulmsten.1 All patients received prophylactic 
antibiotics, and we used the surgical kits from Johnson & Johnson 
(New Brunswick, NJ, USA).
We screened the electronic medical records retrospectively and 
transferred the information to a case report form designed espe‐
cially for the study. The following preoperative data were included: 
type of UI (SUI/MUI), age at time of surgery (≤49, 50‐59, ≥60 years), 
parity (0‐1, 2, 3+), body mass index, past hysterectomy (total and 
subtotal) and relevant comorbidities (cardiovascular disease/diabe‐
tes [0/1], pulmonary disease [0/1] and neurological disease [0/1]). 
From the preoperative examination prior to primary surgery, we col‐
lected the following information: previous conservative treatment 
for UI (pelvic floor muscle training and electrical stimulation), uro‐
flowmetry assessments (including the shape of the curve and the es‐
timate of maximum flow rate [< or ≥15 mL/s]). In addition, the results 
from two standardized stress tests (coughing during gynecological 
Key message
Tension‐free vaginal tape is a surgical method with high 
safety and efficacy with low risk of serious long‐term tape 
complications. However, mixed urinary incontinence pre‐
dicts a shorter long‐term cure.
F I G U R E  1   Flowchart of study participation. TVT, tension‐free 
vaginal tape [Color figure can be viewed at wileyonlinelibrary.com]
Eligible patients  (n = 895)
Burch procedure due to prolapse (n = 26)
Previous pelvic floor surgery (n = 60)
• Urinary incontinence (n = 28)
• Prolapse  (n = 24)
• Concomitant urinary incontinence and 
prolapse surgery (n = 8)
Concomitant prolapse surgery (n = 5)
Primary incontinence surgeries other than TVT (n = 183)
• Open Burch procedures (n = 127)
• Laparoscopically performed Burch procedures (n = 42)
• Others (n = 14)
Primary TVT surgeries (n = 621)
No follow-up (n = 25)
Primary TVT surgeries (n = 596)
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examination with 300 mL saline in the bladder and/or pad weight 
before and after three forceful coughs and 20 jumping jacks [side‐
ways splits]) and cystometry as well as measurement of residual 
urine (mL) were included.16,17
The classification of the type of incontinence was based on a 
combination of symptoms documented in the medical record, out‐
come of stress tests, and/or urodynamic examinations and a stan‐
dardized validated short‐form UI disease‐specific questionnaire 
used since 2002.18 We defined SUI as bothersome symptoms of SUI 
as described in the medical record and/or in the standardized ques‐
tionnaire in combination with a positive stress test. MUI was defined 
as a combination of a dominant SUI component and urgency uri‐
nary incontinence defined as description of bothersome symptoms 
of involuntary leakage of urine after sudden urgency to void in the 
medical record and/or in the standardized questionnaire. A positive 
cystometry was not mandatory for a diagnosis.
Primary outcome was recurrence of UI defined as the presence 
of any bothersome symptoms of SUI reported by the patient and/or 
by a stress urinary incontinence index score >0 indicative of both‐
ersome symptoms of SUI on the validated questionnaire and/or a 
positive standardized stress test at follow up. Neither de novo ur‐
gency urinary incontinence in women with pure SUI before surgery 
nor recurrence of urgency urinary incontinence in women with pre‐
operative MUI was defined as recurrence.
Secondary outcomes were urinary retention (UR), other periop‐
erative complications and late tape complications.
Urinary retention was defined as the need for catheterization 
more than 1 week after primary surgery and/or in need of traction 
and/or surgical correction necessitating cutting of the tape. Traction 
was performed non‐invasively by stretching the urethra with a 
Hegar dilator in gel anesthesia.
Other perioperative complications comprised bladder injury 
defined as perforation by the trocar or by the tape, hematoma de‐
fined as clinical significant and/or ultrasonographically identified 
hematomas of any size and other complications. We chose not to 
include urinary infections as a complication as the prevalence will be 
underestimated most often when these infections are treated post 
discharge by general practitioners.
We defined late tape complications as symptomatic or asymp‐
tomatic erosions, fistulas, and symptoms of dyspareunia and/or 
chronic pain/discomfort diagnosed 3 months or later after primary 
surgery. Recurrent urinary infections without any other complaints 
were not considered to be a late complication, and de novo urgency 
urinary incontinence in SUI women was not included in the study.
All patients were offered a follow up after 6‐12 months with 
an interview and a clinical examination, followed by urodynamics 
if there were bothersome symptoms. In the interview, the women 
were asked about their satisfaction with the treatment, and from 
2002 and onwards the department used a standardized question‐
naire including the categories “very satisfied”, “satisfied”, “neither 
satisfied nor dissatisfied”, “dissatisfied” and “very dissatisfied”. For 
patients residing far from our hospital, we performed the interview 
by post or phone.
Later follow‐up data were based on consultations at our outpa‐
tient clinic after referral from general practitioners or private gyne‐
cologists. For patients not residing in the local catchment area of 
our hospital (n = 166), we retrieved follow‐up data from the medical 
records at relevant local hospitals from in‐ and/or outpatient visits. 
As the department introduced a standardized 3‐year follow‐up using 
the validated short‐form UI disease‐specific questionnaire from 
2009 and onwards, we assessed changes in outcomes in three dif‐
ferent time periods (1998‐2003, 2004‐2008 and 2009‐2012).
2.1 | Statistical analyses
In this case‐series, the data were analyzed using SPSS version 25 
(IBM, Armonk, NY, USA). Pearson chi‐square test was used when 
comparing SUI and MUI, survival analysis (life tables) when esti‐
mating cumulative cure rates of TVT, and Cox regression analysis 
in the risk factor analysis of recurrence. In the survival analysis 
and the Cox regression analysis of recurrence, UI was recorded 
at the date of the first visit for bothersome symptoms of SUI fol‐
lowing primary surgery, or censored at the date of last visit being 
continent as documented in the medical record, or at the date of 
repeat surgery due to complications or prolapse, when repeat 
surgery occurred prior to debut of SUI symptoms. All analyses 
were stopped for any outcome at 10 years of follow up due to the 
small number of observations thereafter. Medical records were 
screened through 1 November 2015.
2.2 | Ethical approval
The Regional Committee for Medical and Health Research Ethics 
(REC‐North ref. number 2012/1238/REK nord; date of approval: 8 
April 2013), and the Patient Ombudsman, Nordland Hospital, Bodø, 
reviewed and approved the study protocol.
3  | RESULTS
Women with MUI as an indication for surgery were significantly 
older, had a higher body mass index and parity order, and more often 
had comorbidities compared with women with pure SUI as the indi‐
cation for surgery (Table 1). Before surgery, women with MUI more 
often practiced electrostimulation alone or in combination with pel‐
vic floor muscle training compared with women with SUI (P < 0.001), 
whereas women with SUI more frequently performed pelvic floor 
muscle training only (Table 2). The preoperative evaluations of the 
stress test, uroflowmetry, cystometry and measurement of residual 
urine were performed in almost all of the women (Table 2).
The surgeries were performed as day surgery procedures from 
2005 and onwards. Mean postoperative hospital stay was 1.0 day 
(range 0‐15). Ten patients (1.7%) had a protracted postoperative hos‐
pital stay of >7 days due to infection and UR.
Of the 596 patients, 499 (83.7%) had their first follow up within 
12 months, 454 (76.2%) visited the outpatient clinic and 45 (7.6%) 
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responded to a standardized questionnaire either by post or phone. 
From interview and questionnaire data at the first postoperative 
follow up, 95.7% of SUI women and 82.1% of MUI women were 
“satisfied” or “very satisfied” (P < 0.01). UR and/or recurrence were 
significantly associated with not being satisfied.
Eighteen patients (3.0%), residing in Nordland County at the time 
of surgery, later moved to other regions of Norway, and 39 patients 
(6.5%) died during follow‐up. These patients were censored at the 
last follow‐up visit if there had been no prior outcome.
3.1 | Efficacy and risk factor analysis
Table 3 summarizes time to last observation for recurrence‐free 
women, events leading to premature discontinuation (censoring) and 
recurrence rates by study group. In 54 (13.8%) SUI women and 52 
(25.2%) MUI women, SUI symptoms recurred within 10 years of sur‐
gery (P = 0.001). There was no difference in the number of cases cen‐
sored by study group (Table 3). Mean recurrence‐free follow‐up time in 
SUI and MUI women was 53.8 and 46.0 months (P = 0.02), respectively.
In the assessment of complications as a risk factor for recurrence, 
perioperative complications with the exception of UR applied only to 
women with SUI: none of the eight MUI women with other periopera‐
tive complications had a recurrence compared with 11 of 25 (44%) SUI 
women. Women with other perioperative complications had a hazard 
ratio (HR) for recurrence of 2.5 (95% CI 1.3‐4.7) relative to women 
without such complications, and mixed incontinent women had an HR 
for recurrence of 2.1 (95% CI 1.4‐3.0) compared with stress‐inconti‐
nent women. Neither age, overweight, parity, previous hysterectomy 
or comorbidities listed in Table 1, nor UR were independent risk fac‐
tors for recurrence and had only minor confounding effects (<4%) on 
the primary outcome. In the same model, the HR for recurrence was 
4.0 (95% CI 2.4‐6.7) in the third compared with the first time period. 
Cumulative cure rates after 1, 5 and 10 years by indication for surgery 
and in total are shown in Table 4. Figure 2 displays continuous cumu‐
lative recurrence rates by indication for surgery.
Two patients (0.3%) had recurrent surgery 17 and 68 months 
after primary surgery, respectively.
3.2 | Complications
In all, 5.2% of the patients had UR (Table 5); 22 of these 31 patients 
recovered within 3 months after surgery (10 recovered spontane‐
ously after a period with self‐catheterization, 10 after traction of 
the tape, and 2 after the tape was cut). Four of the remaining 9 
patients reporting UR more than 3 months after surgery, had the 
tape cut. All patients with UR >3 months after surgery were, after 
TA B L E  1   Preoperative baseline characteristics by indication for 
surgery (%)
SUI (n = 390) MUI (n = 206) P‐value
Age (y)
28‐49 51.3 26.7 <0.001
50‐59 24.6 31.6
60‐93 24.1 41.7
Body mass index (kg/m2)





Para 0‐1 11.8 12.6 0.01
Para 2 42.8 29.6
Para ≥3 45.4 57.8









MUI, mixed urinary incontinence; SUI, stress urinary incontinence.
SUI (n = 390) MUI (n = 206)
Treatment
Electrical stimulation 3.6 14.6
Pelvic floor muscle training 49.0 24.3
Both electrical stimulation and pelvic floor 
muscle training
5.9 16.0
Neither electrical stimulation nor pelvic 
floor muscle training/data missing
41.5 45.1
Clinical assessments performed
Stress test 100.0 99.0
Measure of residual urine 99.2 98.1
Uroflowmetry 94.9 92.7
Cystometry 93.0 97.6
MUI, mixed urinary incontinence; SUI, stress urinary incontinence.
TA B L E  2   Preoperative conservative 
treatment and clinical examinations 
performed by indication for surgery (%)
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a clinical examination, offered cutting of the tape. However, as cut‐
ting the tape entails a risk of recurrent UI, these five patients pre‐
ferred, after extensive counseling, to continue self‐catheterization.
Other perioperative complications remained stable by study 
groups (Table 5) and over the time periods, apart from seven blad‐
der perforations observed during the first time period vs one in the 
third period (P < 0.04). Among patients with other perioperative 
complications, one patient needed evacuation of an infected hema‐
toma and two patients needed repeat surgery with total removal of 
the tape because of pain or graft‐related problems. Three patients 
had the tape removed at primary surgery due to bladder perforation.
In all, 17 (2.9%) women had late tape complications within 
10 years after primary surgery (Table 5). Two women developed a 
fistula, 1 vesico‐ and 1 urethro‐vaginal. Seven of the 12 patients with 
erosions had neither symptoms nor recurrence at the time of diag‐








Time to last observation among recurrence‐free women
Follow up <1 y 18.7 15.0 17.4
Follow up 1‐5 y 28.5 28.6 28.5
Follow up ≥5 y 33.8 25.2 30.9
Events leading to censoring
Removal of tape immediate perioperatively (n = 5) 0.8 1.0 0.8
Other surgery due to other perioperative 
complications (n = 1)
0.3 — 0.2
Urinary retention with cutting of tape (n = 5) 0.5 1.5 0.8
Late tape complications with resection of the tape 
(n = 3)
0.8 — 0.3
Prolapse surgery (n = 18) 2.8 3.4 3.0
Recurrence 13.8 25.2 17.8
MUI, mixed urinary incontinence; SUI, stress urinary incontinence.
TA B L E  3   Summary for recurrence and 
events leading to censoring by indication 
for surgery (%)
TVT surgery risk group 1 y (95% CI) 5 y (95% CI) 10 y (95% CI)
SUI 94% (92%‐96%) 85% (81%‐89%) 74% (66%‐82%)
MUI 88% (84%‐92%) 67% (59%‐75%) 58% (48%‐68%)
Overall cumulative cure 
rate
92% (90%‐94%) 79% (75%‐83%) 69% (63%‐75%)
MUI, mixed urinary incontinence; SUI, stress urinary incontinence.
TA B L E  4   Cumulative cure rates after 1, 
5 and 10 years by indication for surgery 
and in total
F I G U R E  2   Cumulative rates of recurrence of stress 
incontinence after tension‐free vaginal tape surgery by indication 
for surgery. SUI, stress urinary incontinence; MUI, mixed urinary 
incontinence [Color figure can be viewed at wileyonlinelibrary.
com]
TA B L E  5   Complications by indication for surgery (%)
SUI (n = 390)
MUI 
(n = 206)
n % n %
Urinary retention 22 5.6 9 4.4
Other perioperative complications 25 6.4 8 3.9
Bleeding/hematoma 10 2.6 3 1.5
Bladder perforation/injury 10 2.6 2 1.0
Othersa 5 1.3 3 1.5
Late tape complications within 10 y 13 3.3 4 1.9
Erosion 10 2.6 2 1.0
Pain 1 0.3 2 1.0
Fistula 2 0.5 0 0
MUI, mixed urinary incontinence; SUI, stress urinary incontinence.
aFive patients with superficial surgical site infection and 4 patients with 
other complications. 
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there was partial resection of the tape due to erosion (n = 6), fistula 
(n = 1) and pain (n = 1). The second patient with fistula (vesicovagi‐
nal) recovered with conservative treatment. Six patients with ero‐
sion were also treated conservatively with local estrogens without 
surgery. Mean time from primary surgery to surgery for late compli‐
cation was 52 months (range 5‐120 months).
4  | DISCUSSION
Mixed urinary incontinence predicted recurrence 10 years after pri‐
mary TVT surgery. We did not find any association between age, 
overweight, parity, comorbidities, UR and recurrence of SUI.
Among patients not satisfied with the treatment, recurrence 
and UR within 1 year impacted on dissatisfaction. Already at the 
first follow‐up visit we found a significantly lower satisfaction rate 
in MUI‐operated women compared with SUI‐operated women. As 
there were differences in follow‐up time across the study period, 
with a shorter observation time in the third time period relative to 
the previous periods, we performed a Cox regression analysis of 
recurrence over 4 years of observation in order to avoid attrition 
bias. The overall HR for recurrence in the third compared with the 
first time period dropped from 4.0 to 2.2 (95% CI 1.2‐4.0), indi‐
cating that attrition bias may account for 45% of the difference in 
HR for recurrence between the third period and the first. At the 
start of the third time period our department initiated a systematic 
3‐year follow up by a postal questionnaire. A larger proportion of 
women were below 50 years of age (47.8% vs 35.4%) in the third 
time period than in the first. We ascribe this to increasing aware‐
ness of TVT as an improved method for treatment of female incon‐
tinence. Furthermore, a higher expectation for cure after surgery 
may have led some women in the third period to seek medical 
advice for UI at a threshold that may have differed from that of 
women in the first period. These circumstances may have led to a 
reporting bias important for interpretation of the increased HR for 
recurrence in the third vs the first period.
The overall cumulative subjective cure rate after the 10‐year 
follow up (69%) was somewhat lower than results from comparable 
studies (75%‐80%).7,8 When we stratified our results into pure SUI 
and MUI, the cumulative subjective cure rate after the 10‐year fol‐
low up was 74% for the women with pure SUI (95% CI 66%‐82%) and 
58% for the MUI women. The long‐term SUI cure rate was thus lower 
in our study compared with that reported by others (77%‐90%),5,6 
whereas the MUI women had a higher cumulative subjective cure 
rate compared with that of other studies (37%‐55%).11,12 In line with 
other reports we found that the effect of surgery decreased more 
with time in MUI women than in SUI women (Figure 2).19 As our 
study analyzed cure rates using survival analyses, we expected the 
estimates of cure rates to be lower, as recurrence was estimated only 
among patients remaining in the study at the different time intervals. 
This differs significantly from most other studies in which time most 
often is not taken into account when estimating recurrence using the 
total number of patients having surgery as the denominator.5,6,9,10
In studies showing an association between overweight, ad‐
vanced age and lower cure rates, the results may be influenced by 
including in the study populations women with past UI surgery and/
or past or concomitant prolapse surgery, which is not the case in 
our study.
The rates of repeat surgery due to recurrence vary in the liter‐
ature from 0% to 4%.5,6,9,10 Studies reporting “no” repeat surgery 
often comprise low‐risk populations that included only primary sur‐
geries on women with only SUI.5,6
Only a few studies have demonstrated perioperative compli‐
cations as an independent risk factor for recurrence.9,15 Our study 
finds a possible association between recurrence and non‐UR periop‐
erative complications. However, due to the low number of cases 
with such complications and the inconsistency between SUI and 
MUI women, this finding has to be interpreted with caution.
Most studies assessing UR include the need for catheteriza‐
tion resolving spontaneously within 1 week after surgery, leading 
to large variations in published rates of women with postoperative 
UR.20‐22 In our study, only nine patients (1.5%) reported serious 
problems with bladder emptying more than 3 months after surgery. 
Other studies assessing UR after TVT report a 1.2% rate of “very 
disturbing UR” more than 1 year after TVT.21‐23
In 2015, an editorial from the Cochrane Library questioned 
the safety of sub‐urethral slings.24 In that editorial, the authors re‐
ferred to a report from the UK Medicines and Healthcare Products 
Regulatory Agency (MHRA) claiming serious and debilitating 
problems reported by women operated for UI with vaginal tape 
implants.25 However, in our study, only 2.9% of the patients had ex‐
perienced long‐term tape‐related problems. Of these, less than 50% 
were in need of repeat surgery due to complications, and only two 
patients needed major surgery, one due to fistula and one with re‐
section of the tape due to pain. This is in accordance with most other 
long‐term studies stating an incidence of tape complications varying 
from <1% to 3.5%.10,26
Compared with most studies reporting outcome of incontinence 
surgery, our study has a large sample size, long follow‐up time and 
a high follow‐up rate (596/621), as we included information from 
neighboring hospitals in the follow up. To avoid any confounding 
effect of earlier pelvic floor surgery on efficacy, we have included 
only primary surgeries and, in our analysis of recurrence, patients 
were censored at the date of surgery due to prolapse or complica‐
tions. Over the years, surgeries and postoperative follow up have 
been performed in our department in a standardized manner and by 
a limited number of surgeons.
The most important weaknesses of this study are the retro‐
spective design, the possibility for bias due to changes in quality of 
reporting across the study periods, and the possible loss to follow 
up of women having repeat surgery at hospitals in other parts of 
Norway. However, a report from the Auditor General of Norway 
stated that Norwegian patients have high loyalty to their local hospi‐
tals, especially in the rural areas in northern and western Norway.27 
That report supports the escape of patients out of the catchment 
area of our hospital to be of limited magnitude.
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5  | CONCLUSION
Retropubic TVT is a surgical method with high long‐term safety and 
efficacy with low risk of long‐term serious tape complications. MUI 
is a risk factor for long‐term recurrence.
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Abstract
Introduction: The retropubic tension-free vaginal tape procedure has been the pre-
ferred method for primary surgical treatment of stress and stress-dominant mixed 
urinary incontinence in women for more than 20 years. In this study, we assessed as-
sociations between surgeon's experience with the primary tension-free vaginal tape 
procedure and both perioperative complications and recurrence rates.
Material and methods: Using a consecutive case-series design, we assessed 596 pa-
tients treated with primary retropubic tension-free vaginal tape surgery performed 
by 18 surgeons from 1998 through 2012, with follow up through 2015 (maximum 
follow-up time: 10 years per patient). Data on perioperative complications and recur-
rence of stress urinary incontinence from medical records was transferred to a case 
report form. Surgeon's experience with the tension-free vaginal tape procedure was 
defined as number of such procedures performed as lead surgeon (1-19 [“beginners”], 
20-49 and ≥50 procedures). All analyses were done with a 5% level of statistical sig-
nificance. We applied the Chi-square test in the assessment of perioperative compli-
cations. The regression analyses of recurrence rate by number of tension-free vaginal 
tape procedures performed were restricted to the three surgeons who performed 
≥50 procedures.
Results: We found a significantly higher rate of bladder perforations (P = .03) and 
a higher rate of urinary retentions among patients whose tension-free vaginal tape 
procedures were performed by “beginners” (P = .06). We observed a significant re-
duction in recurrence rates with increasing number of tension-free vaginal tape pro-
cedures for one surgeon (P = .03).
Conclusions: Surgeon's experience with the tension-free vaginal tape procedure is 
associated with the risk of bladder perforation and urinary retention, and may be as-
sociated with the long-term effectiveness of the procedure.
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1  | INTRODUC TION
For more than 20 years, the retropubic tension-free vaginal tape 
(TVT) procedure has been the gold standard in primary surgical 
treatment of stress urinary incontinence (SUI) and stress-domi-
nated mixed urinary incontinence in women. Numerous publica-
tions have assessed demographic, clinical and urodynamic risk 
factors for adverse outcomes after mid-urethral sling surgery. 
However, there are few studies assessing surgeon's experience on 
clinical outcomes.
Surgeon's experience is usually characterized by the number of 
TVT procedures performed and/or by the surgeon's position in the 
department (senior consultant/resident) Measures such as organiza-
tional level (university, central or local hospital, teaching/non-teach-
ing hospital) and/or annual volume of surgery are used to describe 
institutions. The majority of publications have assessed periopera-
tive complications by surgeon's experience,1-3 but few studies have 
looked at long-term effectiveness.4-7 Furthermore, most of the stud-
ies that assessed effectiveness by surgeon's experience had low 
sample sizes (<500) and looked at only a few outcomes.4,5,8 Existing 
evidence has shown an increased risk of bladder perforation when 
the surgeon is a “beginner”.9-13
In the TVT procedure, the decreasing rate of bladder perfora-
tion as a function of the increasing number of procedures performed 
has been defined as a possible measure of surgeon's experience.3 
However, studies that have assessed surgeon's experience used 
very different cut-off values to test that experience, <16, <30, <50 
or <100 surgeries.3,10,12 The literature is also inconclusive regard-
ing the surgeon's learning phase when studying urinary retention 
(UR)11,14 and other perioperative complications.1,2,5,8,15 At a 2- and 
4-year follow up, two studies reported reduced cure rates in low- 
versus high-volume departments and when comparing low- versus 
high-volume TVT surgeons.4,6
The aims of this study were to assess associations between sur-
geon's experience with the primary retropubic TVT procedure and 
both perioperative complications and recurrence rates.
2  | MATERIAL AND METHODS
The Department of Gynecology at Nordland Hospital, Bodø, Norway, 
introduced the retropubic TVT procedure in 1998. At that time, none 
of the doctors in the department's permanent staff had any previous 
experience with the procedure; therefore, the first TVT procedures 
in the department were performed by the most experienced senior 
consultants, under the supervision of an experienced urogynecolo-
gist from a university hospital. Less experienced surgeons continued 
to be trained in the procedure by the most experienced surgeons 
until they were judged to be qualified to perform it alone, usually 
after having performed 10-20 TVT procedures.
We recently published a study on clinical outcomes and risk 
factors for recurrence in patients receiving the TVT procedure 
from 1998 through 2012.16 During this period, the Department of 
Gynecology at Nordland Hospital performed 697 TVT procedures, 
621 of which were primary procedures in women with no previous 
incontinence or prolapse surgeries. The present analysis includes the 
596 patients for whom we had follow-up data, which was collected 
through 2015.
The main exposure was surgeon's experience, measured as total 
number of primary TVT procedures performed. Main clinical out-
comes were rate of perioperative complications and recurrence rate.
During the study period, 18 surgeons had the status of lead sur-
geon. Two surgeons operated continuously and performed more 
than two-thirds of the primary TVT procedures (surgeon A, n = 190, 
surgeon B, n = 237) and a third surgeon did 67 primary TVT proce-
dures during the first 5 years of the study period (surgeon C). The re-
maining 15 surgeons (surgeon group D) performed 102 primary TVT 
procedures, varying from 1 to 32 each, mainly before 2007. While 
surgeons A, B and C were specialists in gynecology and obstetrics 
when the TVT procedure was initiated in 1998, surgeon group D 
comprised experienced residents approaching their licensure as gy-
necologists and experienced senior consultants who had performed 
the TVT procedure at other hospitals.
Perioperative complications included UR, bladder injury, he-
matoma and other perioperative complications. UR was defined as 
the need for catheterization more than 1 week after surgery and/or 
need for traction and/or surgical correction necessitating cutting of 
the tape. Bladder injury was defined as perforation by the trocar or 
the tape, and hematoma as clinically significant and/or diagnosed by 
ultrasound. Traction was performed non-invasively by stretching the 
urethra with a Hegar dilator under gel anesthesia. We chose not to 
include urinary infections as complications, as the prevalence would 
have been underestimated because such infections are most often 
treated after discharge by general practitioners.
Recurrence of urinary incontinence was defined as the pres-
ence of any bothersome, patient-reported symptoms of SUI; a SUI 
K E Y W O R D S
complications, long-term results, mixed urinary incontinence, surgeon's experience, tension-
free vaginal tape, stress urinary incontinence
Key message
Patients of surgeons who have less experience with the 
tension-free vaginal tape procedure show higher risks of 
bladder perforations and urinary retention, with less im-
pact on long-term recurrence rates.
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index score >0 indicative of bothersome symptoms of SUI on a 
validated questionnaire17; or a positive standardized cough/jump 
pad stress test.18 Neither de novo urgency urinary incontinence in 
women with pure SUI before the TVT procedure nor recurrence of 
urgency urinary incontinence in women with preoperative mixed 
urinary incontinence was defined as recurrence. All patients were 
followed up either at the outpatient clinic or by post or phone, 
6-12 months after their primary TVT procedure. Between 1998 
and 2008, further follow up occurred only after referral from a 
general practitioner or private gynecologist due to lower urinary 
tract symptoms or other gynecological problems. Patients who 
received the TVT procedure from 2009 onwards had a system-
atic 3-year follow up, comprising a validated short-form urinary 
incontinence disease-specific questionnaire from The Norwegian 
Female Incontinence Registry.17
2.1 | Statistical analyses
Analyses were performed in the Statistical Package for the Social 
Sciences (SPSS) version 25 (IBM) and MATLAB version 2019a. 
Statistical significance was set to a 5% level. In the analysis of perio-
perative complications, we applied the Chi-Square test, categorizing 
the number of primary TVT procedures that surgeons performed as 
1-19 (“beginner”), 20-49, and ≥50.
Recurrence of urinary incontinence was recorded as the date of 
the first visit for bothersome symptoms of SUI following the primary 
TVT procedure, or censored at the date of the last visit at which con-
tinence was documented in the medical record or at the date of re-
peat surgery due to complications or prolapse, when repeat surgery 
occurred prior to debut of SUI symptoms. Each patient was followed 
up for a maximum of 10 years; analyses were stopped for any out-
come thereafter due to few observations.
To maintain power, we restricted analyses of recurrence to sur-
geons A, B and C, as they had performed >50 surgeries. To investi-
gate whether the recurrence rates decreased as the surgeons gained 
more experience, we performed a hypothesis test which stated: the 
recurrence rate is constant and equal to the mean recurrence rate 
over all surgeries (H0) or the recurrence rate is a logit function of 
the number of surgeries performed (H1). These hypotheses give the 
probability (P value) of observing a change in recurrence rate, given 
that the recurrence rate is unaffected by surgeon's experience.
The recurrence rate was estimated using logistic regression, as-
suming a binomial distribution.
The binomial distribution describes a situation in which each 
observation (in this case each TVT procedure) has only two possi-
ble outcomes (in this case recurrence or no recurrence). For each 
surgeon, the first five surgeries in each time period were pooled to 
avoid the effect of highly variable recurrence rates for small number 
of surgeries.
As the department introduced a standardized 3-year follow up 
from 2009 onwards, we performed separate analyses of recurrence 
for 1998-2008 and 2009-2012.
2.2 | Ethical approval
The Regional Committee for Medical and Health Research Ethics 
(REC-North ref. number 2012/1238/REK Nord; date of approval: 8 
April 2013), and the Patient Ombudsman, Nordland Hospital, Bodø, 
reviewed and approved the study protocol.
3  | RESULTS
There were no differences between surgeons regarding indications 
for surgery (SUI/mixed urinary incontinence) or comorbidity (car-
diovascular, pulmonary, or neurological diseases). However, surgeon 
C operated on more women who had undergone a hysterectomy 
(Table 1).
Over the study period, the average annual number of TVT 
procedures performed in the department was 46 (range 27-64). 
Among the 596 primary TVT procedures included in this analysis, 
146 (24.5%) were performed by surgeons with an experience of 
≤19 primary TVT procedures, 103 (17.3%) were performed by sur-
geons with an experience of 20-49 primary TVT procedures, and 
347 (58.2%) were performed by surgeons with an experience of ≥50 
primary TVT procedures.
3.1 | Surgeon's experience and complications
Despite decreasing trends, there were no significant differences in 
the total rate of perioperative complications by category of surgeon's 
experience with the TVT procedure. UR was more often diagnosed 
when surgeons had an experience of ≤19 primary TVT procedures 
(P = .06), whereas the risk of bladder perforation decreased signifi-
cantly when the surgeon had performed ≥50 TVT procedures com-
pared with fewer surgeries (P = .03) (Table 2).
3.2 | Surgeon's experience and effectiveness
There were no statistically significant differences in recurrence 
rates by age, body mass index, parity, earlier hysterectomy or co-
morbidity during follow up (Table 3). Compared with 1998-2008, 
there was a lower proportion of recurrences diagnosed the first 
year after surgery and a higher proportion of recurrences diag-
nosed 3-5 years after surgery in 2009-2012 (P = .00) (Table 4). 
During 1998-2008, mean recurrence rates varied from 10.2% for 
surgeon A (based on this surgeon's TVT procedures 1-98, Figure 1, 
panel A1) to 17.9% for surgeon B (based on this surgeon's TVT 
procedures 1-134, Figure 1, panel B1) (P = .10). These rates nearly 
doubled in 2009-2012, with a mean recurrence rate of 19.6% 
for surgeon A (based on this surgeon's TVT procedures 99-190, 
Figure 1, panel A2) and 30.1% for surgeon B (based on this sur-
geon's TVT procedures 135-237, Figure 1, panel B2) (P = .09). 
During the latter period, recurrence occurred more often among 
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patients who received the TVT procedure for mixed urinary in-
continence (odds ratio 2.4, 95% CI 1.2-4.9) than among those who 
received it for SUI (odds ratio 1.5, 95% CI 0.7-2.9).
In 1998-2008, when surgeons were building competence, 
surgeons A and C had a decreasing slope for the recurrence rate, 
whereas surgeon B had a nearly flat slope (Figure 1, panels A1, B1, 
C1). For surgeon B, this resulted in neither a clinically significant nor 
a statistically significant change in recurrence rate by increasing 
number of surgeries (based on this surgeon's TVT procedures 1-134) 
(P = .71). For surgeon A, the decreasing slope may suggest a clinically 
significant effect on performance by increasing number of surger-
ies (based on this surgeon's TVT procedures 1-98), but it was not 
statistically significant (P = .24). For surgeon C, the recurrence rate 













Age at time of surgery
25-49 years 42.6 49.8 34.3 32.4 42.8 .051
50-59 years 28.4 21.9 34.3 31.4 27.0
60-93 years 28.9 28.3 31.3 36.3 30.2
Body mass index (kg/m2)
Missing 0.5 0.4 1.5 3.9 1.2 .119
18.29-24.99 41.1 33.8 28.4 30.4 34.9
25.00-29.99 40.0 45.6 50.7 48.0 44.8
30.00-42.15 18.4 20.3 19.4 17.6 19.1
Parity
0-1 7.9 13.5 16.4 13.7 12.1 .059
2 41.6 41.8 25.4 32.4 38.3
3+ 50.5 44.7 58.2 53.9 49.7




25.3 21.5 23.9 24.5 23.5 .823
Pulmonary (yes) 15.3 8.9 9.0 15.7 12.1 .112




63.2 65.8 68.7 66.7 65.4 .843
Mixed urinary 
incontinence
36.8 34.2 31.3 33.3 34.6
aPearson Chi-square test. 
TA B L E  1   Baseline characteristics by 
surgeons














Urinary retention 8.2 1.9 4.3 4.9 .059
Other perioperative complications 4.8 9.7 4.6 5.5 .126
Bleeding/hematoma 0.0 2.9 2.9 2.2 .116
Bladder perforation/injury 2.7 5.8 0.6 2.0 .03
Othersb  2.1 1.0 1.2 1.3 .683
Total perioperative complications 13.0 11.7 8.9 10.4 .360
aPearson Chi-square test. 
bFive patients with surgical site infection and four with other complications. 
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significant effect, with fewer recurrences by increasing number of 
surgeries (based on this surgeon's TVT procedures 1-67).
At the start of the 2009-2012 period, surgeons A and B had ex-
perience with 98 and 134 primary TVT procedures, respectively. 
In this period, the slope of the recurrence curve for surgeon A de-
creased slightly for surgeries 99-190 (Figure 1, panel A2) (P = .22), 
which may indicate a clinically significant, but not a statistically 
significant effect of learning, whereas for surgeon B we observed 
nearly no change in the slope for the recurrences for surgeries 135-
237 (panel B2) (P = .77).
4  | DISCUSSION
We did not find any statistically significant differences in the overall 
rate of perioperative complications by surgeon's experience. However, 
surgeons who had performed ≥50 TVT procedures had a significantly 
lower risk of bladder injury compared with surgeons who had per-
formed fewer such procedures. We found a significant reduction in 
recurrence rate by increasing number of TVT procedures performed 
for one of three surgeons, with indifferent results for the other two.
As reported by others,3,10,13 we found a significant, lower risk of 
bladder injury with increasing number of TVT procedures performed 
above 50. However, we found a higher risk of bladder perforation in 
the middle category of surgeon's experience with TVT procedures 
(20-49; 5.8%) compared with the lowest category (“beginner”, 1-19; 
2.7%). This may be an effect of the assistance from an experienced 
surgeon supervising in the “beginner” phase. In Hilton's study,3 which 
assessed learning phases for 16 surgeons performing 1568 TVT 
procedures, the number of TVT procedures necessary to achieve a 
rate of bladder perforation ≤5% varied between 20 and 80 surgeries. 
Whereas Duckett et al found no difference in UR rate between groups 
of surgeons with different levels of experience,14 Lebret et al reported 
a significant, increased risk of UR during the first 50 TVT procedures 
compared with the subsequent 50.11 We found a borderline signif-
icant increased risk of UR during the first 19 TVT procedures com-
pared with the procedures thereafter (Table 2), which may indicate 
that the learning phase covers the first 20-50 TVTs for this particular 
outcome. These results emphasize both individual variations in the 
length of the learning phase3 as well as disparities across outcomes.
Three studies with sample sizes of 187, 809 and 1455 TVT proce-
dures, respectively, all reported evidence of an association between 
a higher level of experience and a lower risk of perioperative compli-
cations.1,2,15 However, we did not find any difference in the overall 
rate of perioperative complications by surgeon's experience, though 
we did find a slight declining trend by increasing number of TVT pro-
cedures (P = .36).
We did not find any statistically significant association between 
surgeon's experience and risk of recurrence in two of three surgeons 
during a maximum of 10 years of patient follow up. However, for sur-
geon A, there was a tendency towards a declining rate of recurrence 
by increasing number of TVT procedures performed in the period 
1998-2008. A statistically significant reduction in recurrence rate 
by number of TVT procedures performed was shown only for sur-
geon C, who was by far the most experienced gynecologist in the 
department. During his early learning phase of about 30 primary TVT 
procedures, he performed a higher proportion of the procedures not 






25-49 years 16.5 .507
50-59 years 16.8
60-93 years 20.6
Body mass index (kg/m2)





















aMaximum patient follow-up time: 10 years. 
bPearson Chi-square test. 
TA B L E  4   Number and proportion of recurrences by months of 
follow up and study period
Months of follow-up
1998-2008 2009-2012
n (%) n (%)
0-11 27 (47.4) 13 (26.5)
12-35 6 (10.5) 8 (16.3)
36-59 4 (7.0) 27 (55.1)
60-120 20 (35.1) 1 (2.0)
In total 57 (100) 49 (100)
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included in the study and participated in the training of less expe-
rienced surgeons to a greater extent than did surgeons A or B. In 
the period 2009-2012, surgeons A and B had already achieved a sig-
nificant level of experience, and inconsistent changes in recurrence 
rates were observed with increasing number of TVT procedures.
In our assessment of clinical outcomes and experience, we as-
sessed individual learning phases for each surgeon with SUI re-
currence rates during a maximum of 10 years of patient follow up. 
Most studies in the literature assessing surgeon's experience com-
pare institutions and groups of surgeons.4-8 However, in our opin-
ion, any effect of learning by experience needs to be transparent on 
an individual level, as there were individual variations in recurrence 
rates among the surgeons in our study. Furthermore, reporting on 
effectiveness as a function of surgeon's experience is inconsistent, 
and very few studies have a sufficiently long follow-up time or a 
large enough sample size to find an effect. Of four studies with-
out any statistically significant findings when comparing effective-
ness between high- and low-volume departments or surgeons,5,7-9 
three had a sample size of <200 women, with a follow-up time of 
less than 2 years. Thus, compared with most studies reporting out-
comes of incontinence surgery, our study has a larger sample size, 
longer follow-up time (10 years) and fewer patients lost to follow up 
(596/621).16
To avoid any confounding effect of earlier pelvic floor surgery, we 
included only patients undergoing primary TVT procedures, and in 
our analysis of recurrence, patients were censored at the date of sur-
gery for both prolapse and complications. The overall SUI recurrence 
rate in our study was 17.8% (Table 3), which is lower than that re-
ported in the literature, where long-term subjective treatment effec-
tiveness after TVT surgery in populations of women with stress and 
mixed urinary incontinence has been reported to be 57%-80%.19-22
The most important weaknesses of this study are the retrospec-
tive design and the possibility of reporting bias due to the observed 
doubling of the recurrence rate from 1998-2008 to 2009-2012. Our 
results showed that between these periods there was a reduction 
in the proportion of recurrences diagnosed within 1 year of sur-
gery (from 47.4% to 26.5%) and an increase in the proportion of re-
currences diagnosed 3-5 years after surgery (from 7.0% to 55.1%) 
(P = .00). We think it is unlikely that this represents an actual in-
crease in the recurrence rate, but rather illustrates the effect of sys-
tematic follow up, in this case the introduction of a systematic 3-year 
follow-up questionnaire that was implemented from 2009 onwards, 
providing a clustering of recurrences 3-5 years after surgery.
We found that recurrence rates by surgeon varied between 
10.2% and 30.1%. However, this apparently high range of variation is 
most likely due both to actual individual variations between surgeons 
F I G U R E  1   Frequency of recurrence by 
number of primary tension-free vaginal 
tape procedures performed by study 
period for surgeons A, B and C. The red 
line shows the fitted model [Color figure 
can be viewed at wileyonlinelibrary.com]
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and to differences in follow up across time periods. We find bias due 
to different case-mix by surgeons unlikely, as higher age, low parity 
order and previous hysterectomy are inconsistently or not reported 
as risk factors for recurrence.16 The recurrence curves by increas-
ing number of surgeries indicate that each surgeon has an individual 
performance level, but our data provide no evidence of any statis-
tically significant effect of better performance in surgeons having 
performed >100 TVT procedures.
5  | CONCLUSIONS
Our data suggest that there is a learning phase for TVT surgeons, and 
that experience is associated with complications as well as long-term 
effectiveness. Furthermore, we found individual variations, and the 
length of the learning phase may vary as well by type of outcome. 
These factors have to be taken into account at teaching hospitals 
when educating residents and young surgeons in new techniques. 
Surgical skills need to be carefully evaluated before “beginners” 
are allowed to perform TVT procedures on their own. Monitoring 
of long-term outcomes is time-demanding, but extremely neces-
sary, as it provides important feedback for surgeons. This empha-
sizes the importance of high-quality national registries such as The 
Norwegian Female Incontinence Registry.
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Norsk kvi n nel ig i nkonti nensreg ister. S pørreskjema for u ri nlekkasje
Registrering før og etter behandling
Dato for innfylling av skjemaet pasientnummer
Vær vennlig besvar alle spørsmå\. De opplysninger som avgis på dette spørreskjema vil bli rapportert til
IVorsk kvinnelig inkontinensregister. Navn og personnummer overtøres ikke. Kun din behandlende lege
kjenner din identitet





når du går i trapper
når du står opp av sengen
når du løfter tungt (tunge bæreposer)




E nel E ikke aktuelt
E nei E ikke aktuelt
E nei E ikke aktuelt
E nei tl ikke aktuelt
L: nei t : ikke aktuelt
r-t nei E ikke aktuelt
E nei E ikke aktuelt
E nei E ikke aktuelt
E nei E ikke aktuelt
1.
Eja






f ] i^. .la
2.
4.
(Krvss av et alternativ for hver av soørsmålene 2 - 6l




E en gang daglig
E mer enn 1 gang daglig
Hvor stor mengde urin lekker du vanligvis ved fysisk aktivitet, når du ler, hoster eller nyser?
E ingen
E dråper/fuktig undertøy
f] drypper / vått undertøy
E renner / går gjennom ytterklær
E renner nedover bena eller ned på gulvet
Hvor ofte opplever du plutselig sterk trang til å late vannet og lekker før du når frem til toilettet?
I aldri
n 'l - 4 ganger per måned
I 1 -6gangerperuke
E en gang daglig
Lr mer enn 'l gang daglig





n renner/ går gjennom ytterklær
E renner nedover bena eller ned på gulvet 
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6, Dersom du har symptomer både som i spørsmål 2 og spørsmål 4, hva er du mest plaget av?
E lekkasje ved fysisk aktivitet mer enn lekkasje ved trang
E lekkasje ved trang mer enn lekkasje ved fysisk aktivitet
E like mye plaget av lekkasje ved trang som ved fysisk aktivitet
I Har ikke lekkasje hverken som ved spørsmål 2 eller 4
(Krvss av et alternativ for hver av soørsmålene 7 - 1 1)
7 . Hvor manoe inkontinensbind bruker du?
B. Hvor mange ganger har du fått behandling for blære katarr de siste 6 måneder?
[J ingen I lgang I 2-3ganger E 4ganger n merenn4
9. Hvor ofte unnlater du aktiviteter (f.eks. en hobby, fysisk trening, eller gå ut) fordi du er redd for å lekke urin?
E aldri I sielden I av oo til [] ofte I alltid
10. Unngår du steder og situasjoner hvor du vet at toilett ikke er lett tilgjengelig?
I ahri I sjelden I av og til I ofte t-] alltid
11. Er ditt seksualliv blitt påvirket av ditt lekkasjeproblem? (skal besvares før behandling)
I ilT: . I uforandret E utitt titt verre E utitt mye verrre
relevant
(Kryss av ja, nei eller ikke aktuellt for alle spørsmål under punkt 12 )
12. Påvirker din lekkasie
dine ferier? r: ja I nei E ikke aktuelt
ditt familieliv? 11 ja ; nei E ikke aktuelt
ditt sosiale liv (å gå ut, å treffe venner)? E ja a nei E ikke aktuelt
din nattesøvn? E ja 3 nei
(lr,ryss av kun et alternativ under spørsmålene 13 og 14)
13. Er ditt seksualliv blitt påvirket av ditt lekkasjeproblem? (skal besvares etter behandling)
I ikke relevant
tr blitt mye bedre I otitt litt bedre tr uforandret I utitt litt verre I utitt mye verrre
14.Er du fornøyd med resultatet av din behandling for hostelekkasje? (besvares etter behandling)
Iveldisfornøyd I tittfornøyd l:Nf[fl;;Jj [_]tittmisfornøyd I veldigmisfornøyd
Pasienten samtykker i at data overføres til Norsk kvinnelig inkontinens register: ja







Fylles inn av helsepersonell etter undersøkelse og behandling
Dato for innfylling av skjemaetilmm
Fylles inn av medisinsk personell.
| | lutredernummer
dato for inkontinens behandlingmmn
| | loperatørnummer
| | | operasjonsnummer
maksimum tukketrykk (cm H2o) m





dato for avbrutt og ikke fullført
inkontinensoperasjonmmu
komplikasjonEja Inei
blæreperforasjon E ja I nei
hematom>3cmEja Inei
overfladisksårinfeksjon E ja ! nei
dypsårinfeksjon E ja ! nei
kateter> l uke< 1mnd, E ja I nei-
kateter> 1 månedE ja Inei
justerebåndoperativtE ja I nei
tarm perforasjon E ja ! nei
karskadeEja Inei
blødning >500m|. E ja I nei
urethraskadeEja Inei
cystitt 14 dg. e. op, D j a ! nei
smerte styrke på skala fra 0 til 10mmm
antall tidligere gjennomgåtte
inkontinensoperasjoner
I nei operert for inkontinens ved vår
avdeling tidliqere
pasientens pnr ved siste
0perasl0n
tr j a ! nei inkontinens og prolapsoperasjon dato for å justere bånd operativt
samtidiq
antall vannlatinger per 24 timer
dato for å klippe bånd
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